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Most of our knowledge on protein tyrosine phosphatases (PTPs) is derived from human pathologies
and mouse knockout models. These models largely correlate well with human disease phenotypes,
but can be ambiguous due to compensatory mechanisms introduced by paralogous genes. Here we
present the analysis of the PTP complement of the fruit ﬂy and the complementary view that PTP
studies in Drosophila will accelerate our understanding of PTPs in physiological and pathological
conditions. With only 44 PTP genes, Drosophila represents a streamlined version of the human com-
plement. Our integrated analysis places the Drosophila PTPs into evolutionary and functional con-
texts, thereby providing a platform for the exploitation of the ﬂy for PTP research and the
transfer of knowledge onto other model systems.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Reversible protein phosphorylation is one of the most wide-
spread mechanisms for controlling cellular functions. Tyrosine
phosphorylation, in particular, has evolved into a sophisticated
regulatory system in metazoans to control many animal-speciﬁc
processes, ranging from development to cellular shape andmotility, transcriptional regulation and proliferation versus differ-
entiation decisions [1]. Out of 498 genes encoding protein kinases
in the human genome, 91 encode tyrosine kinases (TKs) [2]. The set
of TKs is complemented with 109 protein tyrosine phosphatase
(PTP) genes [3], although TKs and PTPs do not seem to have over-
lapping targets.
Given the central importance of tyrosine phosphorylation, it is
no surprise that its abnormal regulation is responsible for many
human diseases: diabetes, obesity, cancer, inﬂammatory diseases,
and many others have been associated with PTP over-expression
or deﬁciencies in human [4]. Historically research on TKs has
advanced at a faster rate than that on PTPs; not only were TKs
identiﬁed nearly a decade earlier than PTPs, but also the intrinsic
difﬁculties of investigating the ‘‘disappearance’’ of a phosphate
moiety as opposed to the appearance of a radioactive phosphate
represented a major burden for the PTP ﬁeld. Major advances have
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where speciﬁc mutations of the PTP catalytic domains allow the
puriﬁcation, detection and identiﬁcation of their physiological sub-
strates. Although PTPs are generally expressed at low levels, they
are enzymatically very active and as a result their ectopic expres-
sion in cellular systems easily leads to off-target effects, usually
resulting in cell death [5]. Therefore, the use of model organisms
is indispensable for the study of PTPs.
Today we know that in most cases phosphatases play a domi-
nant role over protein kinases in shaping the spatio-temporal
dynamics of protein phosphorylation networks, which are
characterized by their amplitude and duration [6]. Thus it has been
proposed that in many instances protein phosphatases make better
drug targets than protein kinases. Most of our current knowledge
on PTPs is derived from mutations identiﬁed in human pathologies
as well as loss-of-function studies in the mouse (embryonic gene
targeting models, and siRNA and shRNA knockdown experiments).
To a large extent, the murine genetic deletions correlate well with
human disease phenotypes and have been instrumental in under-
standing the central importance of PTPs in cellular signaling,
whose effects can range from embryonic-lethal to relatively mild
and nearly unnoticeable likely due to the presence of compen-
satory mechanisms by paralogous PTP genes [4,5]. Whereas the
mouse has so far been the favoured organism for the genetic dis-
section of PTP-controlled pathways, here we argue that
Drosophila melanogaster with its streamlined version of the human
tyrosine phosphatome is a complementary and powerful system
for the dissection of PTP functions in vivo.
The fruit ﬂy occupies a paramount position among model
organisms: Drosophila research yielded the ﬁrst observations on a
wide variety of fundamental biological principles that are con-
served in humans despite several hundred million years of
independent evolution [7–9]. These include the principles of
embryonic patterning by Hox genes, which apply to all bilaterian
animals [10], and the functional conservation of other key signal-
ing pathways, including among others: (i) the Notch signaling
pathway [11–22]; (ii) the Wnt set of signal transduction pathways,
which function in various developmental pathways (body-axis
patterning, cell migration, cell fate speciﬁcation, cell proliferation;
and (iii) the identiﬁcation of the Drosophila receptor tyrosine
kinase gene Sevenless (sev), whose target protein Son of sevenless
(Sos) unveiled the relationship between receptor TK and Ras sig-
naling in eye development [23]. These conserved signaling path-
ways are frequently dysregulated in cancers and type II diabetes
[24–27]).
The main advantage of the ﬂy over other model organisms is
that once a suitable phenotype has been obtained, its genetic
toolkit can be used to dissect the underlying disease pathways
either by loss-of-function (by RNAi, transposon insertion, impre-
cise excision, or X-ray and chemical mutagenesis [28]) or gain-of
function in a tissue-speciﬁc manner (e.g. using the GAL4/UAS sys-
tem [29]. Thus, Drosophila is a particularly attractive system for
establishing models of human disease and studying genetic inter-
actions for a number of reasons [8]: (i) many well-studied biologi-
cal pathways are conserved between human and Drosophila,
including pattern formation, endocrine and intracellular signaling,
and cell death [30]. Furthermore, in recent times the fruit ﬂy has
emerged as an extraordinarily powerful model for the study of
human metabolism, where a homolog of leptin (a hormone that
regulates energy intake and expenditure, including appetite, hun-
ger, metabolism and behavior) called unpaired 2 (upd2, a JAK-
STAT pathway ligand) works similarly to human leptin [31]; (ii)
over 75% of human disease-associated genes have a homolog in
the ﬂy [32], and as such ﬂy models have been successfully estab-
lished for many distinct diseases, including neurodegenerative
disorders, cancer, cardiac, immunological and developmentaldisorders [33]; (iii) its short life cycle and abundant progeny facili-
tates genetic modeling, whereas its relatively short lifespan
(120 days) makes studies on ageing particularly feasible.
Here we describe the PTP complement of D. melanogaster, a
model organism where studies on tyrosine phosphatases have pre-
viously shed light on key pan-metazoan functions. We draw simi-
larities and differences between the tyrosine phosphatome of the
fruit ﬂy and those of human, mouse, worm and yeast, highlighting
important conserved functions that underline the potential of the
fruit ﬂy as a key model organism for the genetic and biochemical
study of tyrosine phosphatases in higher animals.
2. A revised annotation of the Drosophila tyrosine phosphatome
The PTP superfamily is divided into 4 distinct classes that differ
both in their catalytic mechanisms and phosphatase catalytic
domain sequences [34]. Class I are cysteine-based PTPs including
the classical tyrosine-speciﬁc phosphatases (both receptor and
non-receptor), and the dual-speciﬁcity phosphatases (DSP, or
VH1-like). DSPs are the most promiscuous type of PTPs in terms
of substrate speciﬁcity, with some members dephosphorylating
mRNA 50-triphosphate while other enzymes dephosphorylate
lipids. Class II PTPs are a small but evolutionarily highly conserved
group of PTPs with only one member in humans (ACP1); they are
also found in bacteria (which display tyrosine phosphorylation
[35]) and are structurally related to bacterial arsenate reductases.
Class III PTPs, like the Class I and II, are also cysteine-based
enzymes displaying speciﬁcity towards tyrosine and threonine
residues. The human enzymes (CDC25A, CDC25B and CDC25C)
control cell cycle progression by dephosphorylating cyclin-depen-
dent kinases. Despite sharing a cysteine-based catalytic mecha-
nism, Class I, II, and III PTPs are believed to have evolved
independently. A fourth class of PTPs displays an aspartic acid-
based catalytic mechanism with dependence on a cation, and is
represented by the developmentally important EyA (‘Eyes
Absent’) genes, of which only one member is found in the fruit
ﬂy compared to four genes in mouse and human.
We recently developed a highly sensitive and speciﬁc method
for the automatic classiﬁcation of proteins into the various PTP
classes and families (‘Y-Phosphatomer’). Y-Phosphatomer relies
on a speciﬁc collection of protein domain models drawn from
InterPro member databases [3]. Upon evaluation, Y-
Phosphatomer reported perfect coverage and classiﬁcation rates.
Then, as proof of principle we reannotated the human tyrosine
phosphatome and showed that the human genome harbors 109
PTP genes instead of 105 genes as originally reported in a hallmark
paper 10 years ago [34]. We subsequently used Y-Phosphatomer to
annotate the PTP complements of 65 eukaryotic genomes (includ-
ing Drosophila), which are available through the PTP-central data-
base (http://www.PTP-central.org/) [3]. The D. melanogaster
genome contains 44 PTP genes (Fig. 1A), with RNA-seq data from
FlyBase [36] supporting both the robust expression and intron–
exon structures of all PTPs genes. The curated tyrosine phos-
phatome of the ﬂy presented here extends the previous catalogue
of 16 (classical) tyrosine-speciﬁc PTPs [37] by 21 dual-speciﬁcity
phosphatases (DSPs), 4 Class II phosphatases (LMWPs), 2 Class III
phosphatases (CDC25s) and 1 eyes-absent (EyA) homolog
(Table 1).
Previous efforts at characterizing the PTP complement of D. mel-
anogaster include those by Andersen et al. [37] and Morrison et al.
[38]. While the former study exclusively concentrates on Class I
tyrosine-speciﬁc PTPs (and correctly identiﬁes all 16 genes in
Drosophila), the latter is much broader in scope and attempts to
identify all protein kinases and phosphatases in the ﬂy genome.
To do so, Morrison and colleagues mined the ﬂy genome using
Species PTP DSP LMWP CDC25 EyA Total
D. discoideum 13 35 1 1 0 50
S. cerevisiae 8 7 1 1 0 17
S. pombe 4 5 1 1 0 11
C. elegans 99 21 1 4 0 125
D. melanogaster 16 21 4 2 1 44
X. tropicalis 49 53 1 4 4 111
D. rerio 71 88 1 2 4 166
H. sapiens 40 61 1 3 4 109
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Fig. 1. (A) The PTP gene complement of various model organisms, from
Dictyostelium to human. The ﬁgures reported here constitute the automatic
predictions in the PTP-central database [3], which have been manually annotated
for human and Drosophila. (B) Histograms displaying the contribution of each PTP
class to each species’ tyrosine phosphatome. Most of the enlarged repertoire of PTPs
in the worm are tyrosine-speciﬁc PTPs, whereas in Drosophila and vertebrates DSPs
make up as much as half of the organism’s PTP complement. N.B. The various PTP
families are described in detail in Table 1.
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[38] showed that the authors identiﬁed only 80% (36/44) of the
ﬂy’s PTPs, many of which were either incorrectly annotated or at
the time only represented as fragmentary sequences in the
Drosophila genome. This emphasizes the superiority of protein
family-speciﬁc proﬁle hidden Markov model (HMM) methods over
general tools such as BLAST for the database search and automatic
classiﬁcation of proteins into families. Carefully curated HMMTable 1
Comparison of the human and Drosophila tyrosine phosphatomes
PTP classiﬁcation
Class I Classical PTPs R
Classical PTPs N
Dual-speciﬁcity PTPs M
A
S
P
C
P
M
Class II LMWP L
Class III CDC25 C
Asp-based PTPs EYA E
Totalcollections are both especially sensitive and speciﬁc, as we pre-
viously demonstrated for protein kinases [2,40] and ubiquitinating
and deubiquitinating enzymes [41]. The protein models combined
into the Y-Phosphatomer library were speciﬁcally built to repre-
sent the diversity of the PTP repertoire and Y-Phosphatomer out-
performs search efforts that use standard sequence-analysis tools.
3. The Drosophila tyrosine phosphatome is a streamlined
version of the human complement
The D. melanogaster genome contains 44 PTP genes (Table 1,
Fig. 1A). All phylogenetic relationships reported here are those
available on the PTP-central site, and as originally fetched from
the MetaPhOrs database [42]. MetaPhOrs is a public repository of
orthologs and paralogs derived from phylogenetic trees from ﬁve
distinct databases (PhylomeDB [43], Ensembl [44], EggNOG [45],
Hogenom [46] and TreeFAM [47]). Thus, MetaPhOrs is the most
comprehensive database of homology relationships currently
available, and provides speciﬁc metrics to assess the quality of
the PTP homology predictions reported here.
Interrogation of the PTP complements of other model organisms
in PTP-central shows that the proportion of genes encoding PTPs is
kept in strict bounds from yeast to human (0.2% of all genes). The
ﬂy’s PTP complement is larger than that of yeast (17 genes), but
smaller than those of C. elegans (125 genes) or human (109 genes)
(Table 1, Fig. 1). The C. elegans genome, however, is known to have
undergone large protein family expansions in comparison with
other nematodes of similar phenotypic complexity [48], including
11 receptor PTPs harboring unique extracellular domains that are
absent in other species [49].
Whereas 75% of human PTPs are multidomain proteins [34],
only about half of the ﬂy PTPs harbor accessory domains that
enhance the enzymes’ capabilities. In striking contrast, some ser-
ine/threonine phosphatases, such as PP1, mainly consist of small
catalytic subunits that bind regulatory or targeting subunits to
form holoenzymes with different functions. PP1 Ser/Thr phos-
phatases may in principle generate more ﬂexibility and functional
diversity, but strict speciﬁcity must be provided by the PP1-inter-
acting proteins that serve as targeting subunits, substrates and/or
inhibitors [50]. Hence one may argue that the tight regulation typi-
cal of single-chain multidomain PTPs may be better suited to the
speciﬁc regulation of signaling pathways. We describe 17 acces-
sory domains associated with the ﬂy PTPs, which can be classiﬁed
into four main functional categories: (i) cellular localization (e.g.
FERM and PH); (ii) protein–protein interaction (e.g. SH2,
immunoglobulin); (iii) catalytic (e.g. the catalytic domain of
mRNA-capping enzyme); and (iv) small-molecule binding (e.g.split by PTP class and family.
Human Fruit ﬂy
eceptor PTPs 20 8
on-receptor PTPs 20 8
KP 11 2
typical 19 8
lingshots 3 1
RL 3 1
DC14 4 1
TEN 5 1
yotubularins 16 7
MWP 1 4
DC25 3 2
YA 4 1
109 44
PROTEIN TYROSINE PHOSPHATASES (PTP)
(a) Receptor PTPs
 Lar PTPiPTP
Ptp52F PTP
Ptp4E PTP
Ptp10D PTP
Ptp69D PTP PTPi
Ptp99A PTP PTPi
    IA-2 PTPi
I(1)G0232 PTP
Pez PTP
Ptp61F PTP
Ptpmeg PTP
(b) Non-receptor PTPs
        Csw PTP
   PTP-ER PTP
CG42327 PTP
CG7180 PTPi PTPi
Rhodanese-like
Catalytic domain of 
mRNA capping enzyme
SH2
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C-terminus of 
mRNA-capping enzyme
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Cellular localization Protein-protein
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Catalytic
Small-molecule
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Other
Transmembrane helix
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Fibronectin type III
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ZnF FYVE
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DEK
Mop PTPi
Catalytically 
activePTP
PTP domain
catalytic activity
PTPi Catalytically inactive
CG3530 DSP
CG3632 DSP
CG5026 DSPi
Mkp3 DSP
Mtm DSP
Eya EYA
CG14297 LMWP
Primo-2 LMWP
Cdc14 DSP
CG10089 DSP
CG13197 DSP
CG15528 DSP
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Mkp DSP
MKP-4 DSP
Plip DSP
Puc DSP
DUAL-SPECIFICITY PHOSPHATASES (DSP)
        LMWP
EYE ABSENT PHOSPHATASES (EyA)
mRNA-cap DSP
(a) MKP
(b) Atypical
(c) Slingshot
(e) CDC14
(f) PTEN
(g) Myotubularins
CG31469 LMWPi
Primo-1 LMWPi
CG14411 DSPi
EDTP DSP
Sbf DSPi
PRL-1 DSP
(d) PRL
CDC25
Stg CDC25
Twe CDC25
Ssh DSP
Pten DSP
Fig. 2. Protein domain architectures of Drosophila PTPs. We describe 17 accessory domains in association with the ﬂy’s PTPs. Accessory domains impart additional functions,
which can be classiﬁed into four functional categories: cellular localization, protein–protein interaction, catalytic and small-molecule binding. Although comparatively more
human PTPs harbor accessory domains, the types of such domains found both in human and ﬂy PTPs are almost identical.
954 T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966C1) (Fig. 2). It must be noted, however, that although compara-
tively more human PTPs harbor accessory domains, the types of
accessory domains found in both human and ﬂy are almost
identical.
3.1. Drosophila pseudophosphatases
Besides regulation by accessory domains and interacting pro-
teins, PTPs that lack catalytic activity (‘pseudophosphatases’) pro-
vide an additional level of complexity. Proposed functions of
pseudophosphatases include: (i) being part of scaffolding signaling
complexes; (ii) acting as ‘antiphosphatases’ that protect speciﬁc
substrates from other active PTPs; and (iii) working as functional
inhibitors of their substrates to stoichiometrically remove phos-
phorylated proteins from their normal signaling functions, as has
been suggested for the C. elegans pseudophosphatases EGG-4 and
EGG-5 [51,52].
The importance of catalytically inactive enzymes in regulating
key cellular processes was probably ﬁrst understood in the case
of pseudokinases, which act as signal transducers by integrating
signaling network components, as well as being allosteric activa-
tors of active protein kinases [53,54]. In Drosophila, 11/44 (25%)
of PTPs harbor catalytically inactive domains (labeled ‘PTPi’ in
Fig. 2), including 4 receptor (Lar, Ptp69D, Ptp99A and IA-2) and
2 non-receptor PTPs (CG7180 and Mop), 3 myotubularins
(CG5026, CG14411 and Sbf), and 2 LMWPs (Primo-1 and
CG31469). The classiﬁcation of a PTP as a pseudophosphatase is
not as straightforward as it is for protein kinases: a kinase should
lack at least one of three essential motifs in the catalytic domain
(the VAIK, HRD or the DFG motif) to be classiﬁed as a pseudokinase
[53]. In 2001, Andersen et al. [55] described 10 conserved motifs inthe catalytic domain of PTP1B and highlighted speciﬁc amino acids
common to all PTPs that play critical roles in catalysis. We used
both information from the literature and this set of sequence con-
servation criteria to predict the catalytic activity of Drosophila PTPs.
For instance, the second domains (D2) of all receptor PTPs lack a
critical amino acid in motif I (Tyr46 in PTP1B), and mutations of
the general acid donor of the WPD loop (Asp181 in PTP1B) also
render D2 domains catalytically inert. However, D2 domains in
an increasing number of pseudophosphatases appear to have
retained their capacity to bind substrates, potentially acting as
important regulators of signaling pathways.
3.2. Class I PTPs: receptor tyrosine-speciﬁc phosphatases (RPTPs)
Nearly 20% of human PTPs are predicted to contain a transmem-
brane domain [34], a ﬁgure similar to the ﬂy genome where we
have identiﬁed 8 RPTPs (18% of the tyrosine phosphatome), 7 of
which are likely to be active enzymes (Fig. 2). The functions of
RPTPs were ﬁrst described in the development of the ﬂy’s nervous
system where these enzymes are essential for the proper reg-
ulation of axon guidance and synapse formation. Mutations in
Lar, Ptp69D, Ptp99A, Ptp4E, Ptp10D and Ptp52F affect axon guid-
ance, either alone or in combination as each guidance decision
made by embryonic motor axons during outgrowth to their muscle
targets requires a speciﬁc subset of the neural RPTPs. Highly pene-
trant defects in the CNS and motor axon guidance are typically
observed only when speciﬁc combinations of two or more RPTPs
are removed. Functionally the RPTPs can be divided into two
classes: (a) lethals, which have a clear phenotype upon deletion
(Lar, Ptp69D and Ptp52F); and (b) viables, which present no phe-
notype on their own but synergize with each other and with
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(Ptp99A, Ptp10D and Ptp4E). Structurally, 3 RPTPs present tandem
PTP domains (Lar, Ptp69D and Ptp99A, where the second domain,
D2, is catalytically inactive), and a protein architecture reminiscent
of the R1/R6 RPTP subtype. The proposed function of the inactive
D2 domain is to serve as a dynamic modulator of the D1 domain,
which mechanistically could happen in several ways: (i) through
the direct inhibition of the D1 domain by physical hindrance (hinge
vs. head-and-toe models) [56]; (ii) by serving as a redox sensor for
modulating D1 activity [57]; and (iii) possibly D2 could function as
a pseudophosphatase domain that interacts with substrates to pre-
vent them from performing their functions [52]. Five RPTPs in the
ﬂy genome (Ptp4E, Ptp10D, Ptp52F, CG42327 and IA-2) harbor a
single PTP domain.
3.2.1. Tandem domain RPTPs: Lar, Ptp69D and Ptp99A
Drosophila Lar is the ﬂy ortholog of human and mouse R2B sub-
family members PTPRD, PTPRF and PTPRS. Like the human enzymes,
Lar is strongly expressed in the brain and also in tissues of
endodermal origin. Lar has a crucial role in regulating synapse
growth and maturation at the neuromuscular junction, relying on
its ligands Syndecan (Sdc) and Dally-like. Sdc is a heparan sulfate
proteoglycan that contributes to Lar function in motor axon guid-
ance. The overexpression of Sdc in muscles produces the same phe-
notype as the overexpression of Lar in neurons, and the genetic
deletion of Lar suppresses the effect produced by ectopic muscle
Sdc. In muscles Sdc can interact with neuronal Lar and binding
to Sdc increases Lar’s signaling efﬁciency [58]. In contrast, the fam-
ily of extracellular matrix molecules known as chondroitin sulfate
proteoglycans (CSPGs) negatively regulate axonal growth by inter-
acting with neuronal Lar and inactivating the downstream Akt and
RhoA signals. Mice lacking the Lar orthologue do overcome the
neurite growth restrictions imposed by CSPGs in neuronal cultures
[59]. However, the function of Lar in controlling R7 photoreceptor
axon targeting in the visual system differs in a number of respects:
(i) the extracellular domain of Lar is different and might be regu-
lated by other ligands; and (ii) R7 targeting does not require
Lar’s phosphatase activity but relies on that of Ptp69D. Although
Lar’s phosphatase activity is not required for R7, Lar dimerisation
probably leads to the assembly of downstream effectors [60]. Thus,
the genetic deletion of Lar leads to axon elongation and fascic-
ulation deﬁciency, a phenotype that is partially mimicked in com-
pounded mouse knock-outs of the Ptprd and Ptprs genes [61]. In
particular, the mouse Ptprs knockout promotes axonal regenera-
tion and even increases memory and the plasticity of neural inter-
actions in the brain [62]. Similarly, the C. elegans ortholog, ptp-3, is
most highly expressed in the nervous system, from the late embryo
to the adult stages [63]. It thus seems that the original function of
Lar (neuron targeting) has become diversiﬁed in the course of evo-
lution into additional functions of brain patterning and synaptic
interaction formation in mammals. Not surprisingly, both the
mammalian ligand CSPG and the cytoplasmic signaling networks
downstream of the receptors have diverged from those of the ﬂy
[64,65]. Interestingly, recent work suggests that the inhibition of
Ptprs might constitute a novel approach in the treatment of spinal
cord, brain injuries and neurodegenerative diseases [62,66–69].
The two other tandem domain-containing receptor PTPs,
Ptp69D and Ptp99A, are also involved in neural patterning. Their
extracellular domains contain the typical immunoglobulin-like
and ﬁbronectin-like domains that mediate cell–cell interactions.
In contrast to Lar, Ptp69D and Ptp99A have a much smaller num-
ber of ﬁbronectin repeats (3 and 4, respectively). Whereas Ptp99A
has two detectable orthologues in human (PTPRG and PTPRZ1),
Ptp69D is the phylogenetic ortholog of human CD45 (PTPRC), a
key regulator of lymphocyte antigen receptor signaling. However,
adaptive immune mechanisms are absent in the ﬂy. While beingsomewhat functionally redundant, differing expression patterns
in the Drosophila CNS (Ptp69D in young axons, Ptp99A and Lar in
older axons) as well as the study of mutant Lar, Ptp69D and
Ptp99A, indicate that these enzymes may have specialized roles
in CNS development and in the adult brain of the ﬂy [70]. In
embryos lacking Ptp69Dmotor neuron growth cones cease to grow
before reaching their muscle targets, or follow incorrect pathways
that bypass these muscles. Embryos lacking Ptp99A have no distin-
guishable phenotype, but Ptp99A Ptp69D double mutants present a
much more severe phenotype. Therefore, Ptp69D and Ptp99A are
required for motor axon guidance and have partially redundant
roles during the development of the neuromuscular system [71].
Furthermore, Ptp69D seems to function in conjunction with
Ptp10D in bundle formation and is necessary for axonal growth
to the lobes from the peduncle [70], whereas Lar mutants display
a phenotype of axon overgrowth across the midline of the brain
in both larval and adult brains [70]. Given the parallel between
neuronal and immune synapses, it is interesting to note that these
enzymes have acquired additional roles in immunity in higher ani-
mals [72]. For instance the human orthologs of Ptp99A possess an
extracellular carbonic anhydrase domain (absent in ﬂies), responsi-
ble for catalyzing the interconversion of carbon dioxide and bicar-
bonate to maintain the acid-base balance in blood and tissues.
Despite Ptp69D and CD45 (PTPRC) being strict phylogenetic ortho-
logs, their proteins’ extracellular domains are slightly different,
which is understandable since the ﬂy has evolved separately for
over 400 million years to possibly recognize different extracellular
stimuli while maintaining the same intracellular signaling domain
architecture. Finally, the worm ortholog of Ptp69D (clr-1) has non-
neural roles but is also broadly involved in developmental pro-
cesses as it has been shown to be a negative regulator of the FGF
receptor (EGL-15) by dephosphorylation [73].
3.2.2. Ptp4E, Ptp10D and Ptp52F
Ptp4E, Ptp10D and Ptp52F are all structurally similar with a
string of N-terminal ﬁbronectin-like domains and a single, intra-
cellular, active catalytic domain, and all are homologous to
enzymes of the R3 subtype (PTPRB/PTPRO).
Ptp4E and Ptp10D have important roles in neural patterning in
the ﬂy, although their expression pattern is not limited to neurons.
Ptp4E is broadly expressed and its mutants are viable and fertile,
but Ptp4E Ptp10D double mutants have a mild CNS phenotype
and the resulting embryos die before the larval stage. Whereas
Ptp4E Ptp69D double mutants have no phenotype, Ptp10D Ptp69D
double mutants present a strong CNS phenotype, where axons
cross the midline, and the outer and middle longitudinal bundles
are fused to the inner bundle. Therefore both Ptp10D and Ptp69D
are necessary for repulsion of growth cones from the midline of
the embryonic CNS [74,75]. Ptp10D cooperates with Lar, Ptp69D
and Ptp99A to facilitate the outgrowth and bifurcation of the SNa
nerve (one of the ﬁve main nerve branches), but acts in opposition
to the others in regulating the extension of ISN motor axons past
intermediate targets [76]. A GAL4-based screening method devel-
oped by the Zinn laboratory to identify orphan receptor ligands
identiﬁed Stranded at second (Sas) as a Ptp10D ligand required
to prevent longitudinal axons from crossing the midline.
Whereas sas is expressed both in neurons and glia, Ptp10D expres-
sion is restricted to CNS axons [77]. Moreover, in the adult brain,
signaling through Ptp10D is required for long-term memory but
not for learning, early memory or anesthesia-resistant memory
[78].
Studies on compound mutations of both Ptp4E and Ptp10D by
Jeon and Zinn unveiled a complementary role in embryonic tra-
cheal tube formation, which is partly controlled by Ptp4E and
Ptp10D through the down-regulation of the FGFR ortholog (Btl),
Breathless and Pvr receptor tyrosine kinases (which in turn have
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line with other reports on murine members of the R3 subtype, such
as PTPRJ, which also controls receptor tyrosine kinase activity dur-
ing organ development [81,82]. The C. elegans ortholog of Ptp10D
(dep-1) functions through a similar mechanism by negatively regu-
lating EGFR signaling, but instead controls vulval fate during devel-
opment, and duct cell and excretory pore development [83].
Ptp52F is selectively expressed in the CNS of late embryos, where
Ptp52F mRNA knockdown mutants present motor axon and CNS
axon guidance phenotypes. However, this phenotype is suppressed
in Lar Ptp52F double mutants, indicating that these RPTPs compete
in the regulation of CNS axon guidance decisions [84]. An associated
cell surface receptor, Tartan, displays a similar phenotype upon
interference and it has been proposed to be a ligand of Ptp52F
[85]. The expression pattern of Ptp52F is very similar to that of its
mouse ortholog, Ptpro (also known as stomach-associated phos-
phatase or SAP-1) [86]. Therefore, in common with their mouse
orthologs, this set of ﬂy RPTPs have functional roles that extend
beyond the nervous system, and are clearly complementing each
other in controlling phosphotyrosine-based signaling pathways
involved in pattern formation and cell-to-cell interactions.
Furthermore, RNAi-based strategies have shown that Ptp52F
plays an indispensable role in the destruction of the larval midgut
during the larva-to-pupa transition [86]. The destruction of the lar-
val midgut is a critical developmental process triggered by the
molting hormone ecdysone. Ecdysone induces the expression of
Ptp52F, which in turn dephosphorylates Transitional ER ATPase
(Ter94), a regulator of the ubiquitin proteasome system.
Dephosphorylated Ter94 leads to the fast degradation of ubiq-
uitinated proteins, including the Drosophila inhibitor of apoptosis
1 (Diap1) whose degradation is essential for the onset of apoptosis
and the initiation of autophagy [87].
3.2.3. CG42327
Almost nothing is known about the RPTP CG42327 since no
mutants have so far been characterized. The CG42327 gene
achieves expression peaks 12–24 h post-fertilisation, during the
late larval stages and at various stages throughout the pupal per-
iod. In the adult ﬂy CG42327 is particularly highly expressed in
the heart, as well as the eye, the thoracico-abdominal ganglion,
the midgut and the larval/adult hindgut and carcass [36].
3.2.4. IA-2
The eighth RPTP, Islet antigen-2 (IA-2) is the ortholog of the
mammalian genes insulinoma-associated antigen (PTPRN and
PTPRN2), initially described upon detection of high levels of anti-
IA-2 antibodies in type I diabetes patients. Moreover, sera from
type I diabetic patients has been reported to recognize Drosophila
IA-2. Drosophila IA-2 is predicted to be catalytically inactive due
to the lack of the catalytic cysteine (mutated to a glycine residue),
and the replacement of the essential aspartate by an alanine resi-
due. In situ hybridization showed that ia-2 is expressed in the
CNS (the neuronal pattern of expression being similar to that of
mammals), and the midgut region where it plays an important role
in gut development during metamorphosis [88]. Given the
evolutionary conservation of ia-2 genes in Drosophila and C. elegans
(ida-1), both of which lack a pancreas and an adaptive immune sys-
tem, this suggests that essential functions of this pseudophos-
phatase remain to be discovered.
3.3. Class I PTPs: non-receptor tyrosine-speciﬁc phosphatases
Eight non-receptor PTPs are found in the ﬂy genome, which
map to 7 of the 10 human subtypes.3.3.1. CG7180
CG7180 is a PTP gene that we describe here in detail for the ﬁrst
time: CG7180 harbors 2 PTP domains (thus resembling an RPTP)
but lacks any signal peptide or transmembrane segments, and it
is expressed in the late pupal stages, in the central nervous system
of the adult, as well as in other tissues of endodermal origin.
Interestingly only a single transcript encoding 2 exons is reported,
with the 50-terminal exon encoding the entire protein. This is
important, as RPTPs are known to have multiple splice isoforms,
some of which encode only cytoplasmic PTP domains. Therefore
it appears that CG7180 has a unique evolutionary history by encod-
ing a dual catalytic intracellular PTP. Therefore all evidence points
to CG7180 being a cytoplasmic enzyme. Although no clear orthol-
ogy relationships can be ascribed to CG7180, it bears considerable
similarity to a number of receptor PTPs of the R2A subtype (PTPRK,
PTPRM, PTPRT and PTPRU). Sequence similarity is found throughout
the ﬁrst and second PTP domains, and even in the junction
sequence linking them. Two possible hypotheses are that either
the CG7180 gene lost its extracellular domain secondarily, or that
such an extracellular domain was never gained. In the light of
the work by Muller et al. [89], the latter possibility is more plausi-
ble. Upon cloning RPTPs in the sponge Geodia cydonium (sponges
being examples of primitive metazoans as they lack true tissues
or organs, and present no body symmetry), Muller and colleagues
proposed that the ﬁbronectin-containing extracellular domain of
receptor PTPs, and each of their two PTP domains, evolved
independently. The PTP domain would have appeared before the
lineage leading to yeasts, but the extracellular ﬁbronectin domain
likely appeared immediately prior to the emergence of metazoans.
CG7180 thus presents an exciting opportunity to study the evolu-
tion of receptor PTPs with tandem catalytic domains.
Examination of the amino acid sequence of the two catalytic
domains suggests that the D2 domain is catalytically inactive (as
with other D2 domains, the conserved tyrosine residue-Y46 in
PTP1B-present in Motif 1 of the NXXKNRY motif is mutated to an
Aspartate (NREKNRD)). Additionally, the WPD loop motif of the
second domain harbors a methionine instead of the general acid
donor aspartate. Moreover, motif 1 of the D1 domain of CG7180
harbors the sequence NLEKNQN, where the important RY amino
acid pair is missing. Besides, in the WPD loop of D1, a WYS motif
is found with the proline and the crucial aspartate missing.
Therefore, CG7180 is the ﬁrst identiﬁed cytoplasmic enzyme har-
boring 2 pseudophosphatase domains.
3.3.2. Corkscrew
Corkscrew (csw) is the ﬂy ortholog of the SH2 domain-contain-
ing PTPs SHP-1 (PTPN6) and SHP-2 (PTPN11). The structural and
functional characteristics of Corkscrew have been extremely well
conserved in evolution: for instance, the csw mutant phenotype
mimicks gain-of-function mutations typical of the LEOPARD syn-
drome (an autosomal dominant Ras/MAPK multisystem condition
caused by mutations in PTPN11) [90]. Both SHP-1 and SHP-2 play
critical roles in hematopoiesis as positive and negative regulators,
respectively [91]. Moreover, corkscrew is involved in oogenesis and
is a player in terminal cell fate determination [92], a function mir-
rored by the C. elegans ortholog ptp-2 [93].
3.3.3. l(1)G0232
The Drosophila l(1)G0232 gene is orthologous to mammalian
PTPN9 (also known as PTP-MEG2). Eight splice isoforms of
l(1)G0232 mRNA have been reported in the ﬂy (compared to six
in human), all of which encode an active PTP domain plus 1 or 2
CRAL-TRIO domains, except for the shorter isoforms which only
harbor the PTP domain. CRAL-TRIO are 170 amino acid domains
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sent in membrane-associated proteins such as GTPases. Although
l(1)G0232 has not been thoroughly studied, mammalian PTP-
MEG2 has been reportedly associated with secretory vesicles
through its Sec14p domain [94]. Several studies have implicated
PTPN9 in the negative regulation of signaling downstream of
important tyrosine kinase receptors, such as VEGFR in endothelial
cells [95], and ErbB2 and EGFR in breast cancer cell lines [96] by
dephosphorylating STAT3 [97]. STAT3 also appears to be a target
of PTPN9 during primitive hematopoiesis in zebraﬁsh [98].
3.3.4. Mop
The myopic (mop) gene is orthologous to PTPN23 (HD-PTP) in
mammals, and the only PTP in the ﬂy genome harboring a BRO pro-
tein–protein interaction domain. The BRO domain is found in pro-
teins associated with endosomal trafﬁcking through potential
interactions with the Escort III complex. Out of 73 PTPN23 ortho-
logs examined, all but 6 harbor a conserved serine residue
(VHCSSGXG) instead of an alanine residue (VHCSAGXG) in the
PTP signature motif; it has been suggested that this Ala to Ser
mutation in PTPN23 may inﬂuence the entry and positioning of
the substrate in the catalytic pocket [99]. Besides, the D? K muta-
tion in the WPD loop appears to contribute to Mop’s lack of
observed catalytic activity [100]. Despite the abrogation of its cat-
alytic activity,Mop has been reported to act as a tumor suppressor
by inﬂuencing different signaling pathways, for example through
the inhibition of receptor protein kinase signaling during their
endocytic internalization [101], and by interacting and regulating
the transcription factor Yorkie [102]. Human PTPN23 is increas-
ingly recognized as a tumor suppressor since its knockdown leads
to an increased epithelial to mesenchymal transition rate, thus
facilitating migration and tumor cell invasion [103].
3.3.5. Ptpmeg and Pez
Early analysis of non-receptor PTP sequences identiﬁed three
speciﬁc subtypes in the human genome, each exempliﬁed by the
MEG, PEZ and BAS enzymes [104]. In addition to their active cat-
alytic PTP domain, all three contain an N-terminal FERM domain
that is known to anchor proteins onto membrane-associated pro-
teins involved in actin rearrangement and cytoskeleton dynamics.
This classiﬁcation scheme was mainly based on the absence of a
PDZ domain in the PEZ enzymes, the presence of one PDZ domain
in the MEG subfamily, and of multiple PDZ domains in the BAS sub-
family. Such classiﬁcation was retained in the annotation of the
human PTPs by Andersen and colleagues with the subtype names
NT5 (MEG), NT6 (PEZ) and NT7 (BAS) [55]. However, Edwards
et al. noted that no orthologs of human BAS exist in Drosophila, a
ﬁnding that we have conﬁrmed here. Recent work has uncovered
an important function for Drosophila Pez in intestinal stem cells
by acting on the Hippo signaling pathway, which controls organ
growth by regulating cell proliferation and apoptosis. In vitro stud-
ies have shown that the human ortholog (PTPN14) is an evolutiona-
rily conserved regulator of this pathway [105,106], as well as a
regulator of the lymphatic system and choanal development
[107]. PTPN21, the second human ortholog of Drosophila pez, con-
trols proliferation [108]. Recently the group of Norbert Perrimon
have produced a high-resolution interactome of the Hippo path-
way by using existing components of the pathway as TAP-tagged
baits, analysed by mass spectrometry [109].
Ptpmeg is involved in neuronal circuit formation in the central
brain of the ﬂy, regulating both the establishment and stabilization
of axonal projection patterns, and its vertebrate orthologs (PTPN3
and PTPN4) are expressed in the nervous system too [110]. The
human orthologs of Ptpmeg (PTPN3 and PTPN4) are also negative
regulators of T-cell receptor (TCR) signaling (a function absent in
the ﬂy), both dephosphorylating the TCRf chain [111].Additionally, PTPN4 is anti-apoptotic, as was shown by its promo-
tion of the survival of glioblastoma cells, and has been proposed as
a therapeutic target [112].
3.3.6. Ptp61F
Ptp61F is the ﬂy ortholog of mammalian PTPN1 (PTP1B) [113]
and PTPN2 (TC-PTP) [114], and plays fundamental roles in growth,
life span and fecundity [115]. Structurally, Ptp61F contains a PTP
catalytic domain, 2 proline-rich motifs (PXPXXP) and, depending
on the splice isoform, a C-terminus with either a nuclear-targeting
motif (isoform Ptp61Fn), or with a hydrophobic stretch that local-
izes Ptp61F to the cytoplasm (isoform Ptp61Fm) [116].
Interestingly, the multiple functions attributed to Ptp61F relate to
many of the composite functions of mammalian PTPN1 and
PTPN2. For instance, Ptp61F has been found to be both a negative
modulator of the JAK-STAT pathway in Drosophila [117,118] and
mouse [119], and an important modulator of insulin signaling
through dock, the ﬂy ortholog of NCK [120]. Ptp61F has also been
shown to control the organization of F-actin via the regulation of
Kette [121]. More recently, a negative role for Ptp61F has been
found in stem cell maintenance, as well as its inhibition by the
transcription factor Ken [122], and a similar role has been reported
for PTPN2 [123]. The deletion of Ptp61F produces a multitude of
phenotypes reminiscent of a combination of those of mammalian
PTPN1 and PTPN2 [124,125].
3.3.7. PTP-ER
PTP-ER is the phylogenetic ortholog of the R7 subtype receptor
genes PTPRR (HePTP, PTP-SL) and the non-receptor enzymes PTPN5
and PTPN7. PTP-ER mutations have been identiﬁed in the ﬂy where
they affect the development of the R7 photoreceptor, thus support-
ing its function in MAP kinase regulation. Moreover, recent work in
human has shown that PTPRR is an important tumor suppressor in
a variety of malignancies, including breast and ovarian cancer. This
function is likely associated with its role in the negative regulation
of MAP kinase signaling [103,126,127].
3.4. Class I PTPs: dual-speciﬁcity phosphatases (DSPs)
The DSPs constitute the largest and most diverse group of PTPs
whose deﬁning feature is their ability to dephosphorylate both tyr-
osine and serine/threonine residues within the same substrate.
However, we now know that DSPs target a much larger and diverse
set of substrates, including phospho-serine, phospho-threonine
and phospho-tyrosine residues, phosphoinositide lipids, RNA 50-
triphosphate, and carbohydrates. Although both classical PTPs
and DSPs rely on an essential catalytic cysteine residue located at
the base of the catalytic cleft, the catalytic pocket of DSPs is gener-
ally broader and shallower than that of classical PTPs, which
explains why DSPs can accommodate more than one phos-
phorylated residue [128]. The 21 DSP genes of Drosophila can be
classiﬁed into the same seven distinct human families (MKP,
Atypical, Slingshot, PRL, CDC14, PTEN and Myotubularins), and
therefore are a streamlined version of the 61 human DSP genes.
3.4.1. MKPs (mitogen-activated protein kinase phosphatases)
MKP family enzymes are deﬁned by their speciﬁc ability to
dephosphorylate both the phospho-serine and phospho-tyrosine
residues in the activation loop (TxY) of MAP kinases (MAPK), a dual
phosphorylation requirement that is essential for the catalytic
activation of MAPKs by MAP kinase kinases (MEK). MAPKs are typi-
cally part of three-tiered pathways (MAPK/MEK/MEKK) activated
by a variety of stimuli (e.g. growth factors, cytokines, mitogens,
osmotic stress) to enact a diversity of responses (e.g. gene expres-
sion changes, cellular proliferation/differentiation, inﬂammation
and apoptosis). The human genome harbors 14 genes encoding
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pared to only 7 in Drosophila [2]. The dephosphorylation of both
phospho-residues of the MAPK activation loop by MKPs results in
the complete abolition of MAPK catalytic activity. However, the
partial deactivation of MAPKs can be achieved by dephosphorylat-
ing the phosphotyrosine residue of the activation loop of MAPKs by
classical PTPs, including PTPN5 (STEP), PTPN7 (HePTP) and PTPRR
(PTP-SL) [129]. Interestingly, the PTPN5/PTPN7/PTPRR group maps
to a single gene in Drosophila (CG42327). Therefore, both classical
PTPs and DUSPs are essential regulators that functionally overlap
to ﬁne-tune the activities of MAPK-dependent signaling pathways.
MKPs have been shown to shape the duration, magnitude and
spatial organization of MAPK activities, with some MKPs being
speciﬁc towards a single MAPK while other MKPs are able to regu-
late multiple MAPK pathways within the same cell [130]. Whereas
11 MKP genes have been described in human, only two (Mkp3 and
puckered) exist in the ﬂy, and thus Drosophilamight be an ideal sys-
tem to investigate the mechanisms that endow MKPs with spa-
tiotemporal and quantitative control over MAPK responses and
cellular outcomes. Mkp3 (the ﬂy ortholog of human DUSP6,
DUSP7 and DUSP9) was originally characterized as a negative feed-
back regulator of EGFR signaling [131], although today we know
thatMkp3 is one of many such negative regulators of this essential
pathway [132]. Physiologically Mkp3 is a negative modulator of
innate immunity in the ﬂy gut, without which a strong immune
response to the host gut microﬂora would occur [133]. The Mkp3
ortholog DUSP6 has been shown to play roles in both the promo-
tion and inhibition of apoptosis. The pro-apoptotic function of
DUSP6 was shown in a human colorectal cancer cell line where
the authors demonstrated that DUSP6 acts by dephosphorylating
ERK upon activation by P53 [134]. Conversely, expression studies
on human thyroid tumor samples point to a role in the promotion
of tumorigenesis [135]. Overexpression of human DUSP7 is
observed in leukemias, and a role in maintaining pluripotency
has recently been identiﬁed in mouse embryonic stem (ES) cells
[136–138]. Similarly, DUSP9 also maintains pluripotency in ES cells
[139], and additionally DUSP9 polymorphisms are associated with
type 2 diabetes [140,141]. Puckered (Puc) is a negative regulator
of JNK [142] and was named after its mutant phenotype in the ﬂy’s
eye. Its human ortholog, DUSP10, is also known as Jun N-terminal
kinase phosphatase in human, an important down-regulator of
the JNK pathway. DUSP10 is also indirectly a positive regulator of
ERK in a JNK/p38 dependent manner [143]. In inﬂammation,
DUSP10 inhibits chemokine expression and is downregulated by
ASC/PYCARD, a key adaptor protein in the inﬂammatory response
[144].
3.4.2. Atypical DUSPs
Drosophila CG7378, CG10089, CG13197 and CG15528 are atypical
DSPs that we describe here for the ﬁrst time. The human orthologs
of CG7378 (DUSP3, DUSP13, DUSP26, DUSP27 and DUPD1) are
involved in a multitude of processes from cell cycle regulation to
spermatogenesis [145,146]. Therefore ascribing a clear function
to CG7378 is not straightforward. CG10089 is the ﬂy ortholog of
human DUSP15 and DUSP22. DUSP15 displays high levels of expres-
sion in human testis, as does CG10089 in the adult ﬂy testis [145].
DUSP22 is expressed in the testis as well as in other many other tis-
sues [145]. Since CG10089 is paralogous to Mkp, it might have a
similar function in the negative regulation of JNK activity.
CG13197, the ﬂy ortholog of human DUSP11, is a 50-triphosphatase
that preferentially binds RNA, like its paralog mRNA-cap [147,148].
DUSP11 also binds splicing complexes, its expression is controlled
by P53 [149], and may even play a role in inﬂammatory bowel dis-
ease [150].
MAP kinase-speciﬁc phosphatase (Mkp) is a negative regulator
of the JNK pathway [151] and the ﬂy ortholog of DUSP19.DUSP19 has also been shown to regulate JNK signaling by binding
the activator MKK7, which in turn binds JNK, thus enabling
DUSP19 to dephosphorylate JNK [145]. It has been suggested that
DUSP19 might act as a scaffold protein given that DUSP19-
mediated MKK7 inhibition is not dependent on the catalytic activ-
ity of DUSP19 [145]. Aberrant regulation of DUSP19 may also play
a role in malignant pleural mesothelioma as syndecan-1 (a heparin
sulfate proteoglycan), which is aberrantly expressed in malignant
pleural mesothelioma and regulates proliferation in a highly com-
plex way, is known to negative regulate DUSP19 expression [152].
MAPK Phosphatase 4 (MKP-4), like puc, is involved in the inhibi-
tion of JNK activity upon Gram-negative peptidoglycan-induced
activation, thus being part of the Drosophila innate immune system
[153]. Overexpression of MKP-4 has also been shown to negatively
regulate ERK and p38 MAPKs in Drosophila S2 cells, whereMKP-4 is
constitutively expressed [153]. The human ortholog, DUSP12, har-
bors a C-terminal C2H2 zinc ﬁnger domain, which plays a role in
ribosome biosynthesis and cell cycle regulation [154,155]. The
yeast ortholog, YVH1, lacks the zinc ﬁnger domain like MKP-4 but
is equally involved in the assembly of the 60s ribosomal subunit,
glycogen metabolism, gametogenesis and vegetative growth
[156,157]. Furthermore, human DUSP12 overexpression has been
reported in chronic myeloid leukemia, and DUSP12 genetic poly-
morphisms have been associated with type 2 diabetes [158,159].
Interestingly, the C. elegans ortholog, C24F3.2, participates in
reproduction and fat storage [160,161]. Therefore, Drosophila
MKP-4 might also be involved in ribosome biogenesis, as well as
being relevant for the study of type 2 diabetes, and its study might
provide additional insights into the versatile human DUSP12.
The mRNA-capping phosphatase (mRNA-cap) is a highly con-
served bi-functional enzyme with N-terminal 50-triphosphatase
catalytic activity and a C-terminal guanylyl transferase function.
mRNA-cap recognizes the 50 end of eukaryotic mRNA to add the
7-methylguanosine cap which is essential for translation to occur
[162]. The human (RNGTT) and C. elegans (cel-1) mRNA-cap ortho-
logs function similarly to their Drosophila counterpart. However, in
fungi, the triphosphatase and guanylyltransferase activities are
carried out by two separate proteins, Cet1p and Cgt1p respectively,
with a study showing that they can be replaced by the single mam-
malian bi-functional enzyme [163].
PTEN-like phosphatase (Plip) dephosphorylates the lipid signal-
ing molecule phosphatidylinositol 5-phosphate [164]. In
Drosophila, Plip is localized to the mitochondria and plays a role
in ATP production [165]. Its human ortholog, PTPM1, shows some
functional similarities in that PTPM1 is also a mitochondrial phos-
phatase participating in the regulation of ATP production [164].
However, in humans this enzyme also regulates insulin release
[166]. The C. elegans ortholog, F28C6.8, is implicated in growth
and reproduction based on an RNAi screen that resulted in sterile
worms that display a slow growth phenotype [167].
3.4.3. Slingshot phosphatases
Ssh is a coﬁlin phosphatase of the Slingshot family, with an
important role in eye morphogenesis during the assembly of
ommatidia (the basic units of the compound insect eye), where it
works to inhibit actin polymerization by activating coﬁlin [168].
In addition to its catalytic domain, Ssh, like its human orthologs
(SSH1, SSH2 and SSH3), also contains a DEK domain N-terminal
to the phosphatase catalytic domain, and C-terminal serine- and
glutamine-rich regions. The human orthologs act through similar
mechanisms, but they seem to be involved in wound healing by
affecting keratinocyte motility [169], and therefore the original
function of ssh might have diverged in metazoans, but maybe not
the regulatory mechanisms as phosphorylation by Protein Kinase
D (PKD) has recently been identiﬁed as a regulator of both human
SSH1 and Drosophila Ssh [170].
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The Phosphatase of Regenerating Liver (PRL) is an oncogenic
PTP family that was ﬁrst identiﬁed in the regenerating rat liver
[171]. Members of the PRL family can be prenylated, making it
the sole PTP family containing the CAAX C-terminal prenylation
motif, which is responsible for targeting PRLs to the cell and inner
membranes [172]. This prenylation motif is also conserved in the
human and C. elegans orthologs. PRL-1 is the only family member
in Drosophila, and has been reported in the hearts of adult ﬂies at
days 7 and 14 in a recent proteome analysis [173]. The human
orthologs of Drosophila PRL-1 (PTP4A1, PTP4A2 and PTP4A3) have
been associated with cancer cell proliferation, metastasis,
decreased survival time and poor post-operative outcome [174–
177]. The recent characterization of PRL family members (by
whole-mount immunostaining and in situ hybridization) during
the early embryonic development of Drosophila, amphioxus and
zebraﬁsh showed that PRLs are uniformly expressed in the devel-
oping CNS and thus might be involved in early neural development
[178].
3.4.5. CDC14 phosphatases
cdc14 is the ﬂy ortholog of human CDC14A and CDC14B, which
have been implicated in a diversity of cellular processes, including
DNA repair, DNA damage checkpoint control, centrosome splitting,
chromosome segregation and spindle assembly [179]. In
Drosophila, Cdc14 has been reported to play a role in cytokinesis
[180], and displays an afﬁnity for proteins that have been phos-
phorylated by proline-dependent kinases such as CDC2, CDK5,
ERK1 and P38 [181]. The catalytic site of Cdc14 is located at the
C-terminus whereas the substrate speciﬁcity is determined by an
N-terminal recognition pocket [181,182]. The yeast (CDC14) and
C. elegans (cdc-14) orthologs also have functions in cell cycle con-
trol [183,184].
3.4.6. PTEN phosphatases
The phosphatase and tensin homologue deleted from chromo-
some ten (PTEN) is one of the most frequently mutated tumor sup-
pressor genes, and 7 splice variant mRNAs and encoded
polypeptides of the single Drosophila Pten gene have been
described [185]. Since PTEN is such a powerful tumour suppressor,
Pten mutants have recently been engineered to derive new
Drosophila cell lines [186]. PTEN not only targets acidic substrates
in proteins, but can also dephosphorylate the lipid second messen-
ger phosphatidylinositol-3,4,5 (PIP3), thereby regulating the PI3K/
AKT pathway since PIP3s activate PDK1 by recruitment [187]. The
crystal structure of PTEN unveiled an unusually large active site
capable of accommodating the sugar head group of PIP3. This
would enable PTEN to dephosphorylate the 3-position of the inosi-
tol sugar ring to counteract PI3 kinase-dependent signaling
[187,188]. Moreover, the phospholipid-binding C-terminal tensin
phosphatase C2 domain might work to orientate the N-terminal
catalytic domain on the cell membrane, and has been shown to
inhibit cell migration in human cell lines in vitro [188,189]. PTEN
has many roles in vivo, and both the complete and partial loss of
PTEN function promote a diversity of cancers in human and mice.
Furthermore, Pten has recently been shown to have an essential
patterning role during Drosophila wing development [190]. Given
its central importance to the cell, it is not surprising that PTEN is
under tight transcriptional, post-transcriptional (by micro-RNAs)
and post-translational control (e.g. the lipid phosphatase activity
of PTEN is regulated by phosphorylation, oxidation and ubiquitina-
tion) [191]. Moreover, the C-terminus contains several phospho-
rylation sites and a PDZ domain-binding site, adding an
additional level of regulatory control regarding protein localiza-
tion, stability and activity [192].3.4.7. Myotubularin phosphatases
Myotubularins are lipid phosphatases that act upon phos-
phatidylinositol 3-phosphate and phosphatidylinositol (3,5)-bi-
phosphate. Besides the catalytic domain, myotubularins are
characterized by N-terminal PH-GRAM domains (pleckstrin
homology glycosyltransferases, Rab-like GTPase activators and
myotubularins), and each mammalian member of the myotubu-
larin family acts on its own subset of lipid molecules and has its
own specialized function [193]. Of the seven myotubularins iden-
tiﬁed in Drosophila (compared to 15 genes in human), three are
most likely pseudophosphatases [194] (CG5026, CG14411 and
Sbf, Fig. 2). Despite the important involvement of myotubularins
in a multitude of human diseases, only three have been studied
in detail (EDTP, Mtm and Sbf) [195]. EDTP was ﬁrst identiﬁed in
the egg of the ﬂesh ﬂy Sarcophaga peregrina and subsequently
found to play multiple roles starting from oogenesis until early
embryogenesis in the ﬂy [196,197]. The mammalian ortholog of
EDTP (MTMR14) is devoid of protein domains accessory to the cat-
alytic domain (like EDTP), and is highly expressed in muscle tissue
and implicated in the regulation of autophagy [195,198]. MTMR14
mutations have been linked to centronuclear myopathy [199].
Mtm and Sbf play important roles in macrophage cortical remodel-
ing, endolysosomal homeostasis and wound healing, and are
mutually dependent on each other, with Mtm being recruited
and stabilized by the pseudophosphatase Sbf [200,201].
Similarly, human SBF1 interacts with MTMR2 to modulate its
activity [202]. Drosophila mtm has three human orthologs (MTM1,
MTMR1 and MTMR2), which are believed to have undergone neo-
functionalization events. For instance, MTMR2 is a regulator of late
endocytosis, whereas MTM1 is more important in the early endo-
some [193,203,204]. Myotubularins display a propensity for
dimerization. In mammals the orthologs of Drosophila (pseu-
dophosphatase) myotubularins CG5026 (MTMR9) and CG14411
(MTMR12) have also been shown to bind catalytically active
myotubularin family members indicating that these proteins likely
function as adaptors [193]. Perhaps CG5026 and CG14411 also
interact with catalytically active myotubularins, functioning as
adaptors in a manner similar to Sbf. CG3530 is the ﬂy ortholog of
human MTMR6, MTMR7 and MTMR8. MTMR6 plays a role in apop-
tosis and in immunity by negatively regulating CD4+ T cell activa-
tion by inhibiting KCA3.1, a Ca++-activated potassium channel
[193,195,205,206]. MTMR8 is involved in autophagy [207].
CG3632 is the ortholog of humanMTMR3 andMTMR4: unlike other
myotubularins, MTMR3 localizes to the ER and the Golgi [208],
whereas MTMR4 is involved in early endosome sorting and also
regulates BMP signaling [209,210].
3.5. Class II PTPs: low molecular weight phosphatases (LMWPs)
First identiﬁed in thehuman liver [211], LMWPsharbor abi-func-
tional catalytic domain with both tyrosine phosphatase and arsen-
ate reductase activities, and consequently target both phospho-
tyrosines and aryl phosphates [212,213]. Although yeast and mam-
mals possess a single LMWPenzyme (ACP1) (Fig. 1A), 4 LMWPgenes
exist in Drosophila (primo-1, primo-2, CG14297 and CG31469), of
which only 2 (primo-1 and primo-2) have been reported before
(Fig. 2, Supplementary Table 1). Additionally, only two of these four
genes are active phosphatases since both Primo-1 and CG31469 are
pseudophosphatases. Theprimogenesare sonamedbecauseof their
expression in primary pigment cells of the pupal retina [214],
although primo-2 is also highly expressed in the developing gut,
head and central nerve cord axons, both in developing and adult
ﬂies. primo-1 is expressed in all developmental stages except early
embryos, and both primo genes are believed to play crucial roles
in Drosophila neurogenesis [214]. CG14297 is highly expressed in
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960 T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966the testis of the adultmaleﬂy,whereas thepseudophosphatase gene
CG31469has relatively lowexpression levels throughout theﬂy’s life
(although its expression levels peak in the adult midgut and adult
male head). All Drosophila LMWPs (primo-1, primo-2, CG14297 and
CG31469) are orthologous to the ubiquitously expressed human
enzyme red cell acid phosphatase gene (ACP1).ACP1polymorphisms
have been associated with hemolytic conditions such as favism and
hemolytic anemia, which manifests in systemic lupus erythemato-
sus [215,216]. In one colorectal cancer study, anACP1polymorphism
was associated with cancer [217]. Given the divergent functions of
the mammalian and Drosophila LMWPs, it is reasonable to assume
that the functions of the ﬂy enzymes are carried out by other phos-
phatases in mammals.
3.6. Class III PTPs: CDC25 phosphatases
The CDC25 family is represented in Drosophila by the paralo-
gous genes string (stg) and twine (twe). string plays a role at the
start of mitotic events during embryogenesis, oogenesis andregulates proliferation and stem cell maintenance, whereas twine
plays a role in meiosis and oogenesis [218–222]. Furthermore,
the degradation of the Twine protein as triggered by the onset of
zygotic transcription has recently been found to be a critical switch
that allows embryos to progress from the mid-blastula transition
stage onto gastrulation. At this stage the cell cycle is remodeled
from a short S phase and mitosis to the introduction of a longer
S phase and a G2 phase [223]. Accordingly, the human orthologs
CDC25A, CDC25B and CDC25C also play critical roles in mitosis
[224], and their involvement in cancers has been demonstrated
through their association with angiogenesis, invasion and survival
time [225–228]. Saccharomyces cerevisiae harbors only one CDC25
ortholog (calledMIH1), whose expression ﬂuctuates during the cell
cycle, and also plays an essential role in the initiation of mitosis
[229] (N.B. it must be clariﬁed that another yeast gene, also called
CDC25, encodes a GNEF for Ras). Interestingly, the rescue of yeast
CDC25 mutants can be accomplished by wild-type human CDC25,
indicating a strong functional conservation in evolution from yeast
to man [230]. Furthermore, in human there is evidence of
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play a role in the G1/S transition, with CDC25A-blocked cells
arresting in G1 [230,231]. Moreover CDC25A and CDC25B coopera-
tively regulate G2/M, with CDC25B being essential for the initiation
of mitosis [232]. Expression of CDC25C is seen in all phases of the
cell cycle [232]. Given the complexity of multicellular organisms,
such specialization may provide additional checkpoints to main-
tain synchrony in cell division, with the different genes potentially
complementing each other.
3.7. Aspartic acid-based phosphatases: Eye-Absent homologues (EyA)
Eyes-Absent Phosphatases (EyA) are haloacid dehalogenases
that require a metal for catalytic activity and use aspartic acid as
a nucleophile instead of the classic cysteine residue. Drosophila
Eya is involved in numerous processes including the regulation
of the anti-DNA immune response, retinal determination, sper-
matocyte development and oogenesis [233–238]. The human EyA
phosphatases (EYA1, EYA2, EYA3 and EYA4) play crucial
developmental roles in the eye, muscle and ear [239], and similar
regulatory networks have been identiﬁed in Drosophila. For
instance, the Pax-Six-Eya-Dach network is well-characterized in
humans, and orthologs of these proteins exist in the ﬂy [239].
Human EyA phosphatases can shift from the cytoplasm to the
nucleus to regulate post-translational modiﬁcations through his-
tone dephosphorylation [240], but Drosophila Eya appears to be
cytoplasmic only [239]. The C. elegans ortholog (EYA-1) has been
implicated in the regulation of apoptosis and embryogenesis, as
well as in mesoderm determination into either striated muscle or
a coelomocyte fate [241]. Worm EYA-1 is regulated by factors also
present in the ﬂy and human genomes [241].
4. Conclusions and future perspectives
Despite recent efforts on the characterization of the human tyro-
sine phosphatome [3,34], we lack detailed descriptions of the phos-
phatomes of simpler but equally relevant model organisms. The
genome of D. melanogaster encodes 44 PTP genes, representing a
streamlined version of the human tyrosine phosphatome. None of
the fruit ﬂy PTPs is lineage-speciﬁc and all genes have orthologs in
human.Conversely, over 70% (78/109)of humanPTPshave anortho-
log in the fruit ﬂy.Most importantly, ﬂy andhumanPTPs share ahigh
degree of functional conservation despite millions of years of
independent evolution. Drosophila harbors enzymes of the same
PTP families found in human: Transmembrane Classical PTPs
(including all eight subtypes except R4), Non-Receptor PTPs (includ-
ing all ten subtypes except NT4, NT7 and NT8), Dual-Speciﬁcity
Phosphatases (MKP, Atypical, Slingshot, PRL, CDC14, PTEN,
Myotubularin), Class II Cys-based PTPs (LMWP), Class III Cys-based
PTPs (CDC25) and Asp-based PTPs (EyA). Of the ﬂy PTP genes, 12
and 13 are in 1:1 and 1:2 orthology relationships with both mouse
and human (i.e. 25/44 PTPs, or57%); 15 additional PTPs are in a 1:-
many relationship, and four are in amany:1 relationship. Moreover,
ﬁve yeast PTPs and30wormPTPshavehomologs in theﬂy, aswell as
in mouse and human (Supplementary Table 1).
Our analysis of the functional similarities and divergences, and
orthology relationships between the PTPs of the ﬂy and those of
other model organisms suggests that Drosophila is an ideal modern
organism for the study of mammalian PTPs. Drosophila’s stream-
lined tyrosine phosphatome should be more straightforward to
study than those of mouse or human (where many PTP knockouts
display mild effects, suggesting compensatory mechanisms), as it
is much easier to generate compound knockout models in the ﬂy.
Over 75% of human disease-associated genes have a homolog
in the ﬂy [32], and this ﬁgure also holds true for humanPTP-associated diseases [3]. Since the publication of the ﬂy gen-
ome, Drosophila has emerged as a very successful model for a num-
ber of human diseases, including cancer, immunological,
developmental and neurodegenerative disorders [242], as well as
cardiac conditions [8].
Zebraﬁsh has been favoured by a number of groups for the
study of PTPs as this model ﬁsh shares many fundamental pro-
cesses with human [243] and has the great advantage of producing
transparent embryos (whose development can be followed by
time-lapse microscopy). A fundamental disadvantage of zebraﬁsh
is that, although homologs of most human PTPs are found in the
ﬁsh genome, the whole-genome duplication event that occurred
in the teleost lineage ca. 320 million years ago resulted in a large
number of duplicated PTP genes [244,245]. The implication is that
compound knockouts and complicated analyses will be necessary
to dissect sub-functionalization and neo-functionalization events,
as well as compensatory mechanisms. Another popular model
organism, the sea urchin, is a marine invertebrate widely used in
marine, developmental, gene regulation and evolutionary biology
studies [246]. Its PTP complement (n = 66 genes) is 50% larger than
that of the ﬂy, with substantial lineage-speciﬁc expansions unre-
lated to human enzymes [247], and thus is not as ideal as the ﬂy
for investigating human tyrosine phosphatases (see Fig. 3).
In the last 15 years protein kinases have arguably become the
most popular class of drug targets for the pharmaceutical industry,
not only because of their essential roles in regulating cellular pro-
cesses but also because their druggability principles are well
understood [248]. The old concept that the role of phosphatases
is to counteract kinases in linear signaling pathways has become
superseded by the emerging view that phosphatases play a domi-
nant role in the dynamics of phosphorylation networks by intro-
ducing a multitude of negative and positive controls, which in
turn control the amplitude and duration of the signal, thus inﬂu-
encing different sets of target genes [6]. Despite the recognition
of the importance of PTPs in disease and the dominant effect of
phosphatases over kinases, the development of PTP inhibitors has
been hindered because PTPs are extremely difﬁcult to drug with
small molecules given their close structural relationship and the
general hydrophilicity of the compounds identiﬁed by large
pharmacological screens. The failures of the brute-force approach
of high-throughput screening (HTS) for identifying small molecule
inhibitors are well known since most hits thus identiﬁed cannot be
used in vivo as they typically fall short of exhibiting all the desir-
able characteristics (i.e. low toxicity, absorption, metabolism, dis-
tribution and excretion). In this context, the degree of conserved
biology and physiology between ﬂies and humans makes
Drosophila an invaluable model system to overcome some of the
technical difﬁculties associated with the development of PTP inhi-
bitors in disease models. Since Drosophila has high face validity
with respect to human physiology and disease, primary drug
screening could be performed directly in live ﬂies to select high-
quality hits that display desirable features such as bioavailability,
metabolic stability and low toxicity [8]. This approach will enhance
the rate of discovery of PTP inhibitors by reducing the time needed
to identify a small collection of potentially more effective leads for
subsequent validation by traditional HTS methods. This should be
used in combination with genome-wide functional screens with
cultured cells carrying pathway-speciﬁc reporters, which in the
past have successfully identiﬁed new cellular pathways and drug
targets [249]. Ultimately the chemical inhibition of phosphatases
must be understood in terms of phosphatase-substrate networks
to gain a systems-level understanding of the effect of speciﬁc inhi-
bitors; in this context the group of Maja Köhn have applied a com-
putational approach (by integrating information on phosphatases
and their substrates, crystal structures, co-localization and co-
962 T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966expression data) to derive protein phosphatase-substrate networks
on which testable hypotheses can be generated [250]. Despite over
400 million years of independent evolution [251], the tiny fruit ﬂy
once again comes to the rescue of biochemists, geneticists and sys-
tems biologists to help us understand the essential roles of PTPs in
controlling cellular networks and how these can be manipulated
for therapeutic purposes.
Acknowledgements
We are very grateful to Drs. Talila Volk (Weizmann Institute)
and Acaimo González-Reyes (CABD, Spain) for their critical reading
of the manuscript. We also thank Mr. Shaq Liu for excellent sys-
tems support and Ms. Mineko Tanimoto for secretarial assistance.
TH is a holder of the Samuel Lupovitch Graduate Excellence
Fellowship. This work was supported by the WPI Immunology
Frontier Research Center. MLT holds the Jeanne and Jean-Louis
Lévesque Chair in Cancer Research.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2015.03.
005.
References
[1] Miller, W.T. (2012) Tyrosine kinase signaling and the emergence of
multicellularity. Biochim. Biophys. Acta 1823, 1053–1057.
[2] Martin, D.M., Miranda-Saavedra, D. and Barton, G.J. (2009) Kinomer v. 1.0: a
database of systematically classiﬁed eukaryotic protein kinases. Nucleic Acids
Res. 37, D244–D250.
[3] Hatzihristidis, T., Liu, S., Pryszcz, L., Hutchins, A.P., Gabaldon, T., Tremblay,
M.L. and Miranda-Saavedra, D. (2013) PTP-central: a comprehensive resource
of protein tyrosine phosphatases in eukaryotic genomes. Methods.
[4] Hendriks, W.J., Elson, A., Harroch, S., Pulido, R., Stoker, A. and den Hertog, J.
(2013) Protein tyrosine phosphatases in health and disease. FEBS J. 280, 708–
730.
[5] Hendriks, W.J., Elson, A., Harroch, S. and Stoker, A.W. (2008) Protein tyrosine
phosphatases: functional inferences from mouse models and human
diseases. FEBS J. 275, 816–830.
[6] Nguyen, L.K., Matallanas, D., Croucher, D.R., von Kriegsheim, A. and
Kholodenko, B.N. (2013) Signalling by protein phosphatases and drug
development: a systems-centred view. FEBS J. 280, 751–765.
[7] Rajan, A. and Perrimon, N. (2013) Of ﬂies and men: insights on organismal
metabolism from fruit ﬂies. BMC Biol. 11, 38.
[8] Pandey, U.B. and Nichols, C.D. (2011) Human disease models in Drosophila
melanogaster and the role of the ﬂy in therapeutic drug discovery. Pharmacol.
Rev. 63, 411–436.
[9] Ejsmont, R.K. and Hassan, B.A. (2014) The little ﬂy that could: wizardry and
artistry of Drosophila genomics. Genes (Basel) 5, 385–414.
[10] McGinnis, W. and Krumlauf, R. (1992) Homeobox genes and axial patterning.
Cell 68, 283–302.
[11] Artavanis-Tsakonas, S., Rand, M.D. and Lake, R.J. (1999) Notch signaling: cell
fate control and signal integration in development. Science 284, 770–776.
[12] Morgan, T.H. (1917) The theory of the gene. Am. Nat. 51, 513–544.
[13] Morgan, T.H. (1928) The Theory of the Gene, Yale University Press. pp. 77–81.
[14] Wharton, K.A., Johansen, K.M., Xu, T. and Artavanis-Tsakonas, S. (1985)
Nucleotide sequence from the neurogenic locus notch implies a gene product
that shares homology with proteins containing EGF-like repeats. Cell 43,
567–581.
[15] Gaiano, N. and Fishell, G. (2002) The role of notch in promoting glial and
neural stem cell fates. Annu. Rev. Neurosci. 25, 471–490.
[16] Aguirre, A., Rubio, M.E. and Gallo, V. (2010) Notch and EGFR pathway
interaction regulates neural stem cell number and self-renewal. Nature 467,
323–327.
[17] Hitoshi, S. et al. (2002) Notch pathway molecules are essential for the
maintenance, but not the generation, of mammalian neural stem cells. Genes
Dev. 16, 846–858.
[18] Liu, Z.J. et al. (2003) Regulation of Notch1 and Dll4 by vascular endothelial
growth factor in arterial endothelial cells: implications for modulating
arteriogenesis and angiogenesis. Mol. Cell. Biol. 23, 14–25.
[19] Grego-Bessa, J. et al. (2007) Notch signaling is essential for ventricular
chamber development. Dev. Cell 12, 415–429.
[20] Nobta, M., Tsukazaki, T., Shibata, Y., Xin, C., Moriishi, T., Sakano, S., Shindo, H.
and Yamaguchi, A. (2005) Critical regulation of bone morphogenetic protein-
induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1
signaling. J. Biol. Chem. 280, 15842–15848.[21] Bolos, V., Grego-Bessa, J. and de la Pompa, J.L. (2007) Notch signaling in
development and cancer. Endocr. Rev. 28, 339–363.
[22] Bolos, V., Blanco, M., Medina, V., Aparicio, G., Diaz-Prado, S. and Grande, E.
(2009) Notch signalling in cancer stem cells. Clin. Transl. Oncol. 11, 11–19.
[23] Fortini, M.E., Simon, M.A. and Rubin, G.M. (1992) Signalling by the sevenless
protein tyrosine kinase is mimicked by Ras1 activation. Nature 355,
559–561.
[24] Nusse, R. and Varmus, H. (2012) Three decades of Wnts: a personal
perspective on how a scientiﬁc ﬁeld developed. EMBO J. 31, 2670–2684.
[25] Nusse, R., van Ooyen, A., Cox, D., Fung, Y.K. and Varmus, H. (1984) Mode of
proviral activation of a putative mammary oncogene (int-1) on mouse
chromosome 15. Nature 307, 131–136.
[26] Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D. and Nusse,
R. (1987) The Drosophila homolog of the mouse mammary oncogene int-1 is
identical to the segment polarity gene wingless. Cell 50, 649–657.
[27] Morata, G. and Lawrence, P.A. (1977) The development of wingless, a
homeotic mutation of Drosophila. Dev. Biol. 56, 227–240.
[28] Bellen, H.J. et al. (2004) The BDGP gene disruption project: single transposon
insertions associated with 40% of Drosophila genes. Genetics 167, 761–781.
[29] Venken, K.J. and Bellen, H.J. (2007) Transgenesis upgrades for Drosophila
melanogaster. Development 134, 3571–3584.
[30] Adams, M.D. et al. (2000) The genome sequence of Drosophila melanogaster.
Science 287, 2185–2195.
[31] Rajan, A. and Perrimon, N. (2012) Drosophila cytokine unpaired 2 regulates
physiological homeostasis by remotely controlling insulin secretion. Cell 151,
123–137.
[32] Reiter, L.T., Potocki, L., Chien, S., Gribskov, M. and Bier, E. (2001) A systematic
analysis of human disease-associated gene sequences in Drosophila
melanogaster. Genome Res. 11, 1114–1125.
[33] Bier, E. (2005) Drosophila, the golden bug, emerges as a tool for human
genetics. Nat. Rev. Genet. 6, 9–23.
[34] Alonso, A. et al. (2004) Protein tyrosine phosphatases in the human genome.
Cell 117, 699–711.
[35] Chao, J.D., Wong, D. and Av-Gay, Y. (2014) Microbial protein-tyrosine kinases.
J. Biol. Chem. 289, 9463–9472.
[36] Tweedie, S. et al. (2009) FlyBase: enhancing Drosophila gene ontology
annotations. Nucleic Acids Res. 37, D555–D559.
[37] Andersen, J.N., Del Vecchio, R.L., Kannan, N., Gergel, J., Neuwald, A.F. and
Tonks, N.K. (2005) Computational analysis of protein tyrosine phosphatases:
practical guide to bioinformatics and data resources. Methods 35, 90–114.
[38] Morrison, D.K., Murakami, M.S. and Cleghon, V. (2000) Protein kinases and
phosphatases in the Drosophila genome. J. Cell Biol. 150, F57–F62.
[39] Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, D.J. (1990) Basic
local alignment search tool. J. Mol. Biol. 215, 403–410.
[40] Miranda-Saavedra, D. and Barton, G.J. (2007) Classiﬁcation and functional
annotation of eukaryotic protein kinases. Proteins 68, 893–914.
[41] Hutchins, A.P., Liu, S., Diez, D. and Miranda-Saavedra, D. (2013) The
repertoires of ubiquitinating and deubiquitinating enzymes in eukaryotic
genomes. Mol. Biol. Evol. 30, 1172–1187.
[42] Pryszcz, L.P., Huerta-Cepas, J. and Gabaldon, T. (2011) MetaPhOrs: orthology
and paralogy predictions from multiple phylogenetic evidence using a
consistency-based conﬁdence score. Nucleic Acids Res. 39, e32.
[43] Huerta-Cepas, J., Capella-Gutierrez, S., Pryszcz, L.P., Marcet-Houben, M. and
Gabaldon, T. (2014) PhylomeDB v4: zooming into the plurality of
evolutionary histories of a genome. Nucleic Acids Res. 42, D897–D902.
[44] Flicek, P. et al. (2014) Ensembl 2014. Nucleic Acids Res. 42, D749–D755.
[45] Powell, S. et al. (2014) EggNOG v4.0: nested orthology inference across 3686
organisms. Nucleic Acids Res. 42, D231–D239.
[46] Penel, S., Arigon, A.M., Dufayard, J.F., Sertier, A.S., Daubin, V., Duret, L., Gouy,
M. and Perriere, G. (2009) Databases of homologous gene families for
comparative genomics. BMC Bioinformatics 10 (Suppl. 6), S3.
[47] Schreiber, F., Patricio, M., Muffato, M., Pignatelli, M. and Bateman, A. (2014)
TreeFam v9: a new website, more species and orthology-on-the-ﬂy. Nucleic
Acids Res. 42, D922–D925.
[48] Ghedin, E. et al. (2007) Draft genome of the ﬁlarial nematode parasite Brugia
malayi. Science 317, 1756–1760.
[49] Hutter, H. et al. (2000) Conservation and novelty in the evolution of cell
adhesion and extracellular matrix genes. Science 287, 989–994.
[50] Bollen, M., Peti, W., Ragusa, M.J. and Beullens, M. (2010) The extended PP1
toolkit: designed to create speciﬁcity. Trends Biochem. Sci. 35, 450–458.
[51] Cheng, K.C., Klancer, R., Singson, A. and Seydoux, G. (2009) Regulation of
MBK-2/DYRK by CDK-1 and the pseudophosphatases EGG-4 and EGG-5
during the oocyte-to-embryo transition. Cell 139, 560–572.
[52] Tonks, N.K. (2009) Pseudophosphatases: grab and hold on. Cell 139,
464–465.
[53] Boudeau, J., Miranda-Saavedra, D., Barton, G.J. and Alessi, D.R. (2006)
Emerging roles of pseudokinases. Trends Cell Biol. 16, 443–452.
[54] Zeqiraj, E. and van Aalten, D.M. (2010) Pseudokinases-remnants of evolution
or key allosteric regulators? Curr. Opin. Struct. Biol. 20, 772–781.
[55] Andersen, J.N. et al. (2001) Structural and evolutionary relationships among
protein tyrosine phosphatase domains. Mol. Cell. Biol. 21, 7117–7136.
[56] Tremblay, M.L. (2009) The PTP family photo album. Cell 136, 213–214.
[57] Yang, J., Groen, A., Lemeer, S., Jans, A., Slijper, M., Roe, S.M., den Hertog, J. and
Barford, D. (2007) Reversible oxidation of the membrane distal domain of
receptor PTPalpha is mediated by a cyclic sulfenamide. Biochemistry 46,
709–719.
T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966 963[58] Fox, A.N. and Zinn, K. (2005) The heparan sulfate proteoglycan syndecan is an
in vivo ligand for the Drosophila LAR receptor tyrosine phosphatase. Curr.
Biol. 15, 1701–1711.
[59] Fisher, D. et al. (2011) Leukocyte common antigen-related phosphatase is a
functional receptor for chondroitin sulfate proteoglycan axon growth
inhibitors. J. Neurosci. 31, 14051–14066.
[60] Hofmeyer, K. and Treisman, J.E. (2009) The receptor protein tyrosine
phosphatase LAR promotes R7 photoreceptor axon targeting by a
phosphatase-independent signaling mechanism. Proc. Natl. Acad. Sci. U.S.A.
106, 19399–19404.
[61] Uetani, N., Chagnon, M.J., Kennedy, T.E., Iwakura, Y. and Tremblay, M.L.
(2006) Mammalian motoneuron axon targeting requires receptor protein
tyrosine phosphatases sigma and delta. J. Neurosci. 26, 5872–5880.
[62] Horn, K.E. et al. (2012) Receptor protein tyrosine phosphatase sigma
regulates synapse structure, function and plasticity. J. Neurochem. 122,
147–161.
[63] Harrington, R.J., Gutch, M.J., Hengartner, M.O., Tonks, N.K. and Chisholm, A.D.
(2002) The C. elegans LAR-like receptor tyrosine phosphatase PTP-3 and the
VAB-1 Eph receptor tyrosine kinase have partly redundant functions in
morphogenesis. Development 129, 2141–2153.
[64] Van Vactor, D., Wall, D.P. and Johnson, K.G. (2006) Heparan sulfate
proteoglycans and the emergence of neuronal connectivity. Curr. Opin.
Neurobiol. 16, 40–51.
[65] Chagnon, M.J., Uetani, N. and Tremblay, M.L. (2004) Functional signiﬁcance of
the LAR receptor protein tyrosine phosphatase family in development and
diseases. Biochem. Cell Biol. 82, 664–675.
[66] Brown, J.M. et al. (2012) A sulfated carbohydrate epitope inhibits axon
regeneration after injury. Proc. Natl. Acad. Sci. U.S.A. 109, 4768–4773.
[67] Fry, E.J., Chagnon, M.J., Lopez-Vales, R., Tremblay, M.L. and David, S. (2010)
Corticospinal tract regeneration after spinal cord injury in receptor protein
tyrosine phosphatase sigma deﬁcient mice. Glia 58, 423–433.
[68] Duan, Y. and Giger, R.J. (2010) A new role for RPTPsigma in spinal cord
injury: signaling chondroitin sulfate proteoglycan inhibition. Sci Signal 3,
pe6.
[69] Coles, C.H. et al. (2011) Proteoglycan-speciﬁc molecular switch for
RPTPsigma clustering and neuronal extension. Science 332, 484–488.
[70] Kurusu, M. and Zinn, K. (2008) Receptor tyrosine phosphatases regulate birth
order-dependent axonal fasciculation and midline repulsion during
development of the Drosophila mushroom body. Mol. Cell. Neurosci. 38,
53–65.
[71] Desai, C.J., Gindhart Jr., J.G., Goldstein, L.S. and Zinn, K. (1996) Receptor
tyrosine phosphatases are required for motor axon guidance in the
Drosophila embryo. Cell 84, 599–609.
[72] Dustin, M.L. (2012) Signaling at neuro/immune synapses. J. Clin. Invest. 122,
1149–1155.
[73] Kokel, M., Borland, C.Z., DeLong, L., Horvitz, H.R. and Stern, M.J. (1998) Clr-1
encodes a receptor tyrosine phosphatase that negatively regulates an FGF
receptor signaling pathway in Caenorhabditis elegans. Genes Dev. 12, 1425–
1437.
[74] Sun, Q., Bahri, S., Schmid, A., Chia, W. and Zinn, K. (2000) Receptor tyrosine
phosphatases regulate axon guidance across the midline of the Drosophila
embryo. Development 127, 801–812.
[75] Jeon, M., Nguyen, H., Bahri, S. and Zinn, K. (2008) Redundancy and
compensation in axon guidance: genetic analysis of the Drosophila Ptp10D/
Ptp4E receptor tyrosine phosphatase subfamily. Neural Dev. 3, 3.
[76] Sun, Q., Schindelholz, B., Knirr, M., Schmid, A. and Zinn, K. (2001) Complex
genetic interactions among four receptor tyrosine phosphatases regulate
axon guidance in Drosophila. Mol. Cell. Neurosci. 17, 274–291.
[77] Lee, H.K., Cording, A., Vielmetter, J. and Zinn, K. (2013) Interactions between a
receptor tyrosine phosphatase and a cell surface ligand regulate axon
guidance and glial-neuronal communication. Neuron 78, 813–826.
[78] Qian, M., Pan, G., Sun, L., Feng, C., Xie, Z., Tully, T. and Zhong, Y. (2007)
Receptor-like tyrosine phosphatase PTP10D is required for long-term
memory in Drosophila. J. Neurosci. 27, 4396–4402.
[79] Jeon, M., Scott, M.P. and Zinn, K. (2012) Interactions between Type III
receptor tyrosine phosphatases and growth factor receptor tyrosine kinases
regulate tracheal tube formation in Drosophila. Biol. Open 1, 548–558.
[80] Jeon, M. and Zinn, K. (2009) Receptor tyrosine phosphatases control tracheal
tube geometries through negative regulation of Egfr signaling. Development
136, 3121–3129.
[81] Palka, H.L., Park, M. and Tonks, N.K. (2003) Hepatocyte growth factor receptor
tyrosine kinase met is a substrate of the receptor protein-tyrosine
phosphatase DEP-1. J. Biol. Chem. 278, 5728–5735.
[82] Trusolino, L., Bertotti, A. and Comoglio, P.M. (2010) MET signalling: principles
and functions in development, organ regeneration and cancer. Nat. Rev. Mol.
Cell Biol. 11, 834–848.
[83] Berset, T.A., Hoier, E.F. and Hajnal, A. (2005) The C. elegans homolog of the
mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate
binary cell fate decisions. Genes Dev. 19, 1328–1340.
[84] Schindelholz, B., Knirr, M., Warrior, R. and Zinn, K. (2001) Regulation of CNS
and motor axon guidance in Drosophila by the receptor tyrosine phosphatase
DPTP52F. Development 128, 4371–4382.
[85] Bugga, L., Ratnaparkhi, A. and Zinn, K. (2009) The cell surface receptor Tartan
is a potential in vivo substrate for the receptor tyrosine phosphatase Ptp52F.
Mol. Cell. Biol. 29, 3390–3400.[86] Santhanam, A., Liang, S.Y., Chen, D.Y., Chen, G.C. and Meng, T.C. (2012)
Midgut-enriched receptor protein tyrosine phosphatase PTP52F is required
for Drosophila development during larva–pupa transition. FEBS J..
[87] Santhanam, A., Peng, W.H., Yu, Y.T., Sang, T.K., Chen, G.C. and Meng, T.C.
(2014) Ecdysone-induced receptor tyrosine phosphatase PTP52F regulates
Drosophila midgut histolysis by enhancement of autophagy and apoptosis.
Mol. Cell. Biol. 34, 1594–1606.
[88] Kim, J., Bang, H., Ko, S., Jung, I., Hong, H. and Kim-Ha, J. (2008) Drosophila ia2
modulates secretion of insulin-like peptide. Comp. Biochem. Physiol. A: Mol.
Integr. Physiol. 151, 180–184.
[89] Muller, C.I., Blumbach, B., Krasko, A. and Schroder, H.C. (2001) Receptor
protein-tyrosine phosphatases: origin of domains (catalytic domain, Ig-
related domain, ﬁbronectin type III module) based on the sequence of the
sponge Geodia cydonium. Gene 262, 221–230.
[90] Oishi, K. et al. (2009) Phosphatase-defective LEOPARD syndrome mutations
in PTPN11 gene have gain-of-function effects during Drosophila development.
Hum. Mol. Genet. 18, 193–201.
[91] Trop, S., Tremblay, M.L. and Bourdeau, A. (2008) Modulation of bone marrow-
derived endothelial progenitor cell activity by protein tyrosine phosphatases.
Trends Cardiovasc. Med. 18, 180–186.
[92] Perkins, L.A., Larsen, I. and Perrimon, N. (1992) Corkscrew encodes a putative
protein tyrosine phosphatase that functions to transduce the terminal signal
from the receptor tyrosine kinase torso. Cell 70, 225–236.
[93] Gutch, M.J., Flint, A.J., Keller, J., Tonks, N.K. and Hengartner, M.O. (1998) The
Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase
PTP-2 participates in signal transduction during oogenesis and vulval
development. Genes Dev. 12, 571–585.
[94] Saito, K., Williams, S., Bulankina, A., Honing, S. and Mustelin, T. (2007)
Association of protein-tyrosine phosphatase MEG2 via its Sec14p homology
domain with vesicle-trafﬁcking proteins. J. Biol. Chem. 282, 15170–15178.
[95] Hao, Q., Samten, B., Ji, H.L., Zhao, Z.J. and Tang, H. (2012) Tyrosine
phosphatase PTP-MEG2 negatively regulates vascular endothelial growth
factor receptor signaling and function in endothelial cells. Am. J. Physiol. Cell
Physiol. 303, C548–C553.
[96] Yuan, T., Wang, Y., Zhao, Z.J. and Gu, H. (2010) Protein-tyrosine phosphatase
PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor
signaling in breast cancer cells. J. Biol. Chem. 285, 14861–14870.
[97] Su, F. et al. (2012) Protein tyrosine phosphatase Meg2 dephosphorylates
signal transducer and activator of transcription 3 and suppresses tumor
growth in breast cancer. Breast Cancer Res. 14, R38.
[98] Bu, Y. et al. (2014) Protein tyrosine phosphatase PTPN9 regulates erythroid
cell development through STAT3 dephosphorylation in zebraﬁsh. J. Cell Sci..
[99] Gingras, M.C., Zhang, Y.L., Kharitidi, D., Barr, A.J., Knapp, S., Tremblay, M.L. and
Pause, A. (2009) HD-PTP is a catalytically inactive tyrosine phosphatase due
to a conserved divergence in its phosphatase domain. PLoS One 4, e5105.
[100] Chen, D.Y. et al. (2012) The Bro1-domain-containing protein Myopic/HDPTP
coordinates with Rab4 to regulate cell adhesion and migration. J. Cell Sci.
125, 4841–4852.
[101] Miura, G.I., Roignant, J.Y., Wassef, M. and Treisman, J.E. (2008) Myopic acts in
the endocytic pathway to enhance signaling by the Drosophila EGF receptor.
Development 135, 1913–1922.
[102] Gilbert, M.M., Tipping, M., Veraksa, A. and Moberg, K.H. (2011) A screen for
conditional growth suppressor genes identiﬁes the Drosophila homolog of
HD-PTP as a regulator of the oncoprotein Yorkie. Dev. Cell 20, 700–712.
[103] Lin, G., Aranda, V., Muthuswamy, S.K. and Tonks, N.K. (2011) Identiﬁcation of
PTPN23 as a novel regulator of cell invasion in mammary epithelial cells
from a loss-of-function screen of the ‘PTP-ome’. Genes Dev. 25, 1412–1425.
[104] Edwards, K., Davis, T., Marcey, D., Kurihara, J. and Yamamoto, D. (2001)
Comparative analysis of the Band 4.1/ezrin-related protein tyrosine
phosphatase Pez from two Drosophila species: implications for structure
and function. Gene 275, 195–205.
[105] Poernbacher, I., Baumgartner, R., Marada, S.K., Edwards, K. and Stocker, H.
(2012) Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell
proliferation. Curr. Biol. 22, 389–396.
[106] Liu, H., Jiang, D., Chi, F. and Zhao, B. (2012) The Hippo pathway regulates
stem cell proliferation, self-renewal, and differentiation. Protein Cell 3, 291–
304.
[107] Au, A.C., Hernandez, P.A., Lieber, E., Nadroo, A.M., Shen, Y.M., Kelley, K.A.,
Gelb, B.D. and Diaz, G.A. (2010) Protein tyrosine phosphatase PTPN14 is a
regulator of lymphatic function and choanal development in humans. Am. J.
Hum. Genet. 87, 436–444.
[108] Carlucci, A. et al. (2008) Protein-tyrosine phosphatase PTPD1 regulates focal
adhesion kinase autophosphorylation and cell migration. J. Biol. Chem. 283,
10919–10929.
[109] Kwon, Y., Vinayagam, A., Sun, X., Dephoure, N., Gygi, S.P., Hong, P. and
Perrimon, N. (2013) The Hippo signaling pathway interactome. Science 342,
737–740.
[110] Whited, J.L., Robichaux, M.B., Yang, J.C. and Garrity, P.A. (2007) Ptpmeg is
required for the proper establishment and maintenance of axon projections
in the central brain of Drosophila. Development 134, 43–53.
[111] Bauler, T.J., Hendriks, W.J. and King, P.D. (2008) The FERM and PDZ domain-
containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both
dispensable for T cell receptor signal transduction. PLoS One 3, e4014.
[112] Babault, N. et al. (2011) Peptides targeting the PDZ domain of PTPN4 are
efﬁcient inducers of glioblastoma cell death. Structure 19, 1518–1524.
964 T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966[113] Feldhammer, M., Uetani, N., Miranda-Saavedra, D. and Tremblay, M.L. (2013)
PTP1B: a simple enzyme for a complex world. Crit. Rev. Biochem. Mol. Biol.
48, 430–445.
[114] Bussieres-Marmen, S., Hutchins, A.P., Schirbel, A., Rebert, N., Tiganis, T.,
Fiocchi, C., Miranda-Saavedra, D. and Tremblay, M.L. (2013) Characterization
of PTPN2 and its use as a biomarker. Methods.
[115] Buszard, B.J., Johnson, T.K., Meng, T.C., Burke, R., Warr, C.G. and Tiganis, T.
(2013) The nucleus- and endoplasmic reticulum-targeted forms of protein
tyrosine phosphatase 61F regulate Drosophila growth, life span, and
fecundity. Mol. Cell. Biol. 33, 1345–1356.
[116] Ursuliak, Z., Clemens, J.C., Dixon, J.E. and Price, J.V. (1997) Differential
accumulation of DPTP61F alternative transcripts: regulation of a protein
tyrosine phosphatase by segmentation genes. Mech. Dev. 65, 19–30.
[117] Baeg, G.H., Zhou, R. and Perrimon, N. (2005) Genome-wide RNAi analysis of
JAK/STAT signaling components in Drosophila. Genes Dev. 19, 1861–1870.
[118] Muller, P., Kuttenkeuler, D., Gesellchen, V., Zeidler, M.P. and Boutros, M.
(2005) Identiﬁcation of JAK/STAT signalling components by genome-wide
RNA interference. Nature 436, 871–875.
[119] Pike, K.A., Hutchins, A.P., Vinette, V., Theberge, J.F., Sabbagh, L., Tremblay,
M.L. and Miranda-Saavedra, D. (2014) Protein tyrosine phosphatase 1B is a
regulator of the interleukin-10-induced transcriptional program in
macrophages. Sci. Signal 7, ra43.
[120] Wu, C.L., Buszard, B., Teng, C.H., Chen, W.L., Warr, C.G., Tiganis, T. and Meng,
T.C. (2011) Dock/Nck facilitates PTP61F/PTP1B regulation of insulin
signalling. Biochem. J. 439, 151–159.
[121] Ku, H.Y., Wu, C.L., Rabinow, L., Chen, G.C. and Meng, T.C. (2009) Organization
of F-actin via concerted regulation of Kette by PTP61F and dAbl. Mol. Cell.
Biol. 29, 3623–3632.
[122] Issigonis, M. and Matunis, E. (2012) The Drosophila BCL6 homolog ken and
Barbie promotes somatic stem cell self-renewal in the testis niche. Dev. Biol.
368, 181–192.
[123] Bourdeau, A., Trop, S., Doody, K.M., Dumont, D.J. and Tremblay, M.L. (2013)
Inhibition of T cell protein tyrosine phosphatase enhances interleukin-18-
dependent hematopoietic stem cell expansion. Stem Cells 31, 293–304.
[124] Bourdeau, A., Dube, N. and Tremblay, M.L. (2005) Cytoplasmic protein
tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-
PTP. Curr. Opin. Cell Biol. 17, 203–209.
[125] Tiganis, T. (2013) PTP1B and TCPTP-nonredundant phosphatases in insulin
signaling and glucose homeostasis. FEBS J. 280, 445–458.
[126] Su, P.H. et al. (2012) Epigenetic silencing of PTPRR activates MAPK signaling,
promotes metastasis and serves as a biomarker of invasive cervical cancer.
Oncogene.
[127] Chirivi, R.G., Noordman, Y.E., Van der Zee, C.E. and Hendriks, W.J. (2007)
Altered MAP kinase phosphorylation and impaired motor coordination in
PTPRR deﬁcient mice. J. Neurochem. 101, 829–840.
[128] Denu, J.M. and Dixon, J.E. (1998) Protein tyrosine phosphatases: mechanisms
of catalysis and regulation. Curr. Opin. Chem. Biol. 2, 633–641.
[129] Tonks, N.K. (2006) Protein tyrosine phosphatases: from genes, to function, to
disease. Nat. Rev. Mol. Cell Biol. 7, 833–846.
[130] Caunt, C.J. and Keyse, S.M. (2012) Dual-speciﬁcity MAP kinase phosphatases
(MKPs): shaping the outcome of MAP kinase signalling. FEBS J..
[131] Kim, S.E., Kim, S.H. and Choi, K.Y. (2003) Regulation of drosophila MKP-3 by
drosophila ERK. Ann. N. Y. Acad. Sci. 1010, 51–61.
[132] Butchar, J.P. et al. (2012) New negative feedback regulators of Egfr signaling
in Drosophila. Genetics 191, 1213–1226.
[133] Leulier, F. and Royet, J. (2009) Maintaining immune homeostasis in ﬂy gut.
Nat. Immunol. 10, 936–938.
[134] Piya, S., Kim, J.Y., Bae, J., Seol, D.W., Moon, A.R. and Kim, T.H. (2012) DUSP6 is
a novel transcriptional target of p53 and regulates p53-mediated apoptosis
by modulating expression levels of Bcl-2 family proteins. FEBS Lett. 586,
4233–4240.
[135] Degl’innocenti, D. et al. (2012) DUSP6/MKP3 is over-expressed in papillary
and poorly-differentiated thyroid carcinoma and contributes to the
neoplastic properties of thyroid cancer cells. Endocr. Relat. Cancer.
[136] Levy-Nissenbaum, O., Sagi-Assif, O., Raanani, P., Avigdor, A., Ben-Bassat, I.
and Witz, I.P. (2003) Overexpression of the dual-speciﬁcity MAPK
phosphatase PYST2 in acute leukemia. Cancer Lett. 199, 185–192.
[137] Levy-Nissenbaum, O. et al. (2003) Dual-speciﬁcity phosphatase Pyst2-L is
constitutively highly expressed in myeloid leukemia and other malignant
cells. Oncogene 22, 7649–7660.
[138] Abujarour, R., Efe, J. and Ding, S. (2010) Genome-wide gain-of-function
screen identiﬁes novel regulators of pluripotency. Stem Cells 28, 1487–1497.
[139] Li, Z. et al. (2012) BMP4 signaling acts via dual-speciﬁcity phosphatase 9 to
control ERK activity in mouse embryonic stem cells. Cell Stem Cell 10, 171–
182.
[140] Li, H. et al. (2012) A genome-wide association study identiﬁes GRK5 and
RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes.
[141] Fukuda, H. et al. (2012) A single nucleotide polymorphism within DUSP9 is
associated with susceptibility to type 2 diabetes in a Japanese population.
PLoS One 7, e46263.
[142] McEwen, D.G. and Peifer, M. (2005) Puckered, a Drosophila MAPK
phosphatase, ensures cell viability by antagonizing JNK-induced apoptosis.
Development 132, 3935–3946.
[143] Finch, A.R., Caunt, C.J., Perrett, R.M., Tsaneva-Atanasova, K. and McArdle, C.A.
(2012) Dual speciﬁcity phosphatases 10 and 16 are positive regulators ofEGF-stimulated ERK activity: indirect regulation of ERK signals by JNK/p38
selective MAPK phosphatases. Cell. Signal. 24, 1002–1011.
[144] Taxman, D.J. et al. (2011) The NLR adaptor ASC/PYCARD regulates DUSP10,
mitogen-activated protein kinase (MAPK), and chemokine induction
independent of the inﬂammasome. J. Biol. Chem. 286, 19605–19616.
[145] Patterson, K.I., Brummer, T., O’Brien, P.M. and Daly, R.J. (2009) Dual-
speciﬁcity phosphatases: critical regulators with diverse cellular targets.
Biochem. J. 418, 475–489.
[146] Rahmouni, S. et al. (2006) Loss of the VHR dual-speciﬁc phosphatase causes
cell-cycle arrest and senescence. Nat. Cell Biol. 8, 524–531.
[147] Yuan, Y., Li, D.M. and Sun, H. (1998) PIR1, a novel phosphatase that exhibits
high afﬁnity to RNA. ribonucleoprotein complexes. J. Biol. Chem. 273, 20347–
20353.
[148] Deshpande, T., Takagi, T., Hao, L., Buratowski, S. and Charbonneau, H. (1999)
Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA 50-
triphosphatase and diphosphatase activities. J. Biol. Chem. 274, 16590–
16594.
[149] Caprara, G., Zamponi, R., Melixetian, M. and Helin, K. (2009) Isolation and
characterization of DUSP11, a novel p53 target gene. J. Cell Mol. Med. 13,
2158–2170.
[150] Hasler, R. et al. (2011) Alterations of pre-mRNA splicing in human
inﬂammatory bowel disease. Eur. J. Cell Biol. 90, 603–611.
[151] Kim, Y.I., Ryu, T., Lee, J., Heo, Y.S., Ahnn, J., Lee, S.J. and Yoo, O. (2010) A
genetic screen for modiﬁers of Drosophila caspase Dcp-1 reveals caspase
involvement in autophagy and novel caspase-related genes. BMC Cell Biol.
11, 9.
[152] Szatmari, T., Mundt, F., Heidari-Hamedani, G., Zong, F., Ferolla, E.,
Alexeyenko, A., Hjerpe, A. and Dobra, K. (2012) Novel genes and pathways
modulated by syndecan-1: implications for the proliferation and cell-cycle
regulation of malignant mesothelioma cells. PLoS One 7, e48091.
[153] Sun, L., Yu, M.C., Kong, L., Zhuang, Z.H., Hu, J.H. and Ge, B.X. (2008) Molecular
identiﬁcation and functional characterization of a Drosophila dual-speciﬁcity
phosphatase DMKP-4 which is involved in PGN-induced activation of the JNK
pathway. Cell. Signal. 20, 1329–1337.
[154] Kozarova, A., Hudson, J.W. and Vacratsis, P.O. (2011) The dual-speciﬁcity
phosphatase hYVH1 (DUSP12) is a novel modulator of cellular DNA content.
Cell Cycle 10, 1669–1678.
[155] Muda, M., Manning, E.R., Orth, K. and Dixon, J.E. (1999) Identiﬁcation of the
human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc
binding domain essential for in vivo function. J. Biol. Chem. 274, 23991–
23995.
[156] Kemmler, S., Occhipinti, L., Veisu, M. and Panse, V.G. (2009) Yvh1 is required
for a late maturation step in the 60S biogenesis pathway. J. Cell Biol. 186,
863–880.
[157] Beeser, A.E. and Cooper, T.G. (2000) The dual-speciﬁcity protein phosphatase
Yvh1p regulates sporulation, growth, and glycogen accumulation
independently of catalytic activity in Saccharomyces cerevisiae via the cyclic
AMP-dependent protein kinase cascade. J. Bacteriol. 182, 3517–3528.
[158] Das, S.K. et al. (2006) Polymorphisms in the glucokinase-associated, dual-
speciﬁcity phosphatase 12 (DUSP12) gene under chromosome 1q21 linkage
peak are associated with type 2 diabetes. Diabetes 55, 2631–2639.
[159] Biernacki, M.A. et al. (2010) Efﬁcacious immune therapy in chronic
myelogenous leukemia (CML) recognizes antigens that are expressed on
CML progenitor cells. Cancer Res. 70, 906–915.
[160] Colaiacovo, M.P., Stanﬁeld, G.M., Reddy, K.C., Reinke, V., Kim, S.K. and
Villeneuve, A.M. (2002) A targeted RNAi screen for genes involved in
chromosome morphogenesis and nuclear organization in the Caenorhabditis
elegans germline. Genetics 162, 113–128.
[161] Ashraﬁ, K., Chang, F.Y., Watts, J.L., Fraser, A.G., Kamath, R.S., Ahringer, J. and
Ruvkun, G. (2003) Genome-wide RNAi analysis of Caenorhabditis elegans fat
regulatory genes. Nature 421, 268–272.
[162] Cowling, V.H. (2010) Regulation of mRNA cap methylation. Biochem. J. 425,
295–302.
[163] Schwer, B., Lehman, K., Saha, N. and Shuman, S. (2001) Characterization of
the mRNA capping apparatus of Candida albicans. J. Biol. Chem. 276, 1857–
1864.
[164] Pagliarini, D.J., Worby, C.A. and Dixon, J.E. (2004) A PTEN-like phosphatase
with a novel substrate speciﬁcity. J. Biol. Chem. 279, 38590–38596.
[165] Chang, Y.C., Hung, W.T., Chang, H.C., Wu, C.L., Chiang, A.S., Jackson, G.R. and
Sang, T.K. (2011) Pathogenic VCP/TER94 alleles are dominant actives and
contribute to neurodegeneration by altering cellular ATP level in a Drosophila
IBMPFD model. PLoS Genet. 7, e1001288.
[166] Pagliarini, D.J., Wiley, S.E., Kimple, M.E., Dixon, J.R., Kelly, P., Worby, C.A.,
Casey, P.J. and Dixon, J.E. (2005) Involvement of a mitochondrial phosphatase
in the regulation of ATP production and insulin secretion in pancreatic beta
cells. Mol. Cell 19, 197–207.
[167] Simmer, F. et al. (2003) Genome-wide RNAi of C. elegans using the
hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 1, E12.
[168] Lin, C.M., Lin, P.Y., Li, Y.C. and Hsu, J.C. (2012) Capulet and Slingshot share
overlapping functions during Drosophila eye morphogenesis. J. Biomed. Sci.
19, 46.
[169] Kligys, K., Claiborne, J.N., DeBiase, P.J., Hopkinson, S.B., Wu, Y., Mizuno, K. and
Jones, J.C. (2007) The slingshot family of phosphatases mediates Rac1
regulation of coﬁlin phosphorylation, laminin-332 organization, and motility
behavior of keratinocytes. J. Biol. Chem. 282, 32520–32528.
T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966 965[170] Barisic, S., Nagel, A.C., Franz-Wachtel, M., Macek, B., Preiss, A., Link, G., Maier,
D. and Hausser, A. (2011) Phosphorylation of Ser 402 impedes phosphatase
activity of slingshot 1. EMBO Rep. 12, 527–533.
[171] Mohn, K.L., Laz, T.M., Hsu, J.C., Melby, A.E., Bravo, R. and Taub, R. (1991) The
immediate-early growth response in regenerating liver and insulin-
stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and
identiﬁcation of 41 novel immediate-early genes. Mol. Cell. Biol. 11, 381–
390.
[172] Rios, P., Li, X. and Kohn, M. (2012) Molecular mechanisms of the PRL
phosphatases. FEBS J..
[173] Cammarato, A. et al. (2011) A mighty small heart: the cardiac proteome of
adult Drosophila melanogaster. PLoS One 6, e18497.
[174] Lu, J.W., Chang, J.G., Yeh, K.T., Chen, R.M., Tsai, J.J., Su, W.W. and Hu, R.M.
(2012) Increased expression of PRL-1 protein correlates with shortened
patient survival in human hepatocellular carcinoma. Clin. Transl. Oncol. 14,
287–293.
[175] Krndija, D. et al. (2012) The phosphatase of regenerating liver 3 (PRL-3)
promotes cell migration through Arf-activity-dependent stimulation of
integrin alpha5 recycling. J. Cell Sci. 125, 3883–3892.
[176] Tamagawa, H. et al. (2012) The expression of the phosphatase regenerating
liver 3 gene is associated with outcome in patients with colorectal cancer.
Hepatogastroenterology 59.
[177] Sun, Z.H. and Bu, P. (2012) Downregulation of phosphatase of regenerating
liver-3 is involved in the inhibition of proliferation and apoptosis induced by
emodin in the SGC-7901 human gastric carcinoma cell line. Exp. Ther. Med.
3, 1077–1081.
[178] Lin, M.D. et al. (2013) Expression of phosphatase of regenerating liver family
genes during embryogenesis: an evolutionary developmental analysis
among Drosophila, amphioxus, and zebraﬁsh. BMC Dev. Biol. 13, 18.
[179] Mocciaro, A. and Schiebel, E. (2010) Cdc14: a highly conserved
family of phosphatases with non-conserved functions? J. Cell Sci. 123,
2867–2876.
[180] Gregory, S.L., Shandala, T., O’Keefe, L., Jones, L., Murray, M.J. and Saint, R.
(2007) A Drosophila overexpression screen for modiﬁers of Rho signalling in
cytokinesis. Fly (Austin) 1, 13–22.
[181] Gray, C.H. and Barford, D. (2003) Getting in the ring: proline-directed
substrate speciﬁcity in the cell cycle proteins Cdc14 and CDK2-cyclinA3. Cell
Cycle 2, 500–502.
[182] Gray, C.H., Good, V.M., Tonks, N.K. and Barford, D. (2003) The structure of the
cell cycle protein Cdc14 reveals a proline-directed protein phosphatase.
EMBO J. 22, 3524–3535.
[183] Traverso, E.E., Baskerville, C., Liu, Y., Shou, W., James, P., Deshaies, R.J. and
Charbonneau, H. (2001) Characterization of the Net1 cell cycle-dependent
regulator of the Cdc14 phosphatase from budding yeast. J. Biol. Chem. 276,
21924–21931.
[184] Roy, S.H., Clayton, J.E., Holmen, J., Beltz, E. and Saito, R.M. (2011) Control of
Cdc14 activity coordinates cell cycle and development in Caenorhabditis
elegans. Mech. Dev. 128, 317–326.
[185] Di Cristofano, A. and Pandolﬁ, P.P. (2000) The multiple roles of PTEN in tumor
suppression. Cell 100, 387–390.
[186] Justiniano, S.E., Mathew, A., Mitra, S., Manivannan, S.N. and Simcox, A. (2012)
Loss of the tumor suppressor Pten promotes proliferation of Drosophila
melanogaster cells in vitro and gives rise to continuous cell lines. PLoS One 7,
e31417.
[187] Song, M.S., Salmena, L. and Pandolﬁ, P.P. (2012) The functions and regulation
of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283–296.
[188] Lee, J.O. et al. (1999) Crystal structure of the PTEN tumor suppressor:
implications for its phosphoinositide phosphatase activity and membrane
association. Cell 99, 323–334.
[189] Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S. and Hall, A.
(2004) Regulation of cell migration by the C2 domain of the tumor
suppressor PTEN. Science 303, 1179–1181.
[190] Bardet, P.L. et al. (2013) PTEN controls junction lengthening and stability
during cell rearrangement in epithelial tissue. Dev. Cell 25, 534–546.
[191] Leslie, N.R. and Foti, M. (2011) Non-genomic loss of PTEN function in cancer:
not in my genes. Trends Pharmacol. Sci. 32, 131–140.
[192] Tonks, N.K. (2012) Protein tyrosine phosphatases: from housekeeping
enzymes to master-regulators of signal transduction. FEBS J..
[193] Mruk, D.D. and Cheng, C.Y. (2011) The myotubularin family of lipid
phosphatases in disease and in spermatogenesis. Biochem. J. 433,
253–262.
[194] Nandurkar, H.H. et al. (2003) Identiﬁcation of myotubularin as the lipid
phosphatase catalytic subunit associated with the 3-phosphatase adapter
protein, 3-PAP. Proc. Natl. Acad. Sci. U.S.A. 100, 8660–8665.
[195] Amoasii, L., Hnia, K. and Laporte, J. (2012) Myotubularin phosphoinositide
phosphatases in human diseases. Curr. Top. Microbiol. Immunol. 362, 209–
233.
[196] Yamaguchi, S., Katagiri, S., Sekimizu, K., Natori, S. and Homma, K.J. (2005)
Involvement of EDTP, an egg-derived tyrosine phosphatase, in the early
development of Drosophila melanogaster. J. Biochem. 138, 721–728.
[197] Yamaguchi, S., Homma, K. and Natori, S. (1999) A novel egg-derived tyrosine
phosphatase, EDTP, that participates in the embryogenesis of Sarcophaga
peregrina (ﬂesh ﬂy). Eur. J. Biochem. 259, 946–953.
[198] Vergne, I., Roberts, E., Elmaoued, R.A., Tosch, V., Delgado, M.A., Proikas-
Cezanne, T., Laporte, J. and Deretic, V. (2009) Control of autophagy initiation
by phosphoinositide 3-phosphatase Jumpy. EMBO J. 28, 2244–2258.[199] Tosch, V. et al. (2006) A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with
an inactivating variant in centronuclear myopathy. Hum. Mol. Genet. 15,
3098–3106.
[200] Jean, S., Cox, S., Schmidt, E.J., Robinson, F.L. and Kiger, A. (2012) Sbf/MTMR13
coordinates PI(3)P and Rab21 regulation in endocytic control of cellular
remodeling. Mol. Biol. Cell 23, 2723–2740.
[201] Velichkova, M., Juan, J., Kadandale, P., Jean, S., Ribeiro, I., Raman, V., Stefan, C.
and Kiger, A.A. (2010) Drosophila Mtm and class II PI3K coregulate a PI(3)P
pool with cortical and endolysosomal functions. J. Cell Biol. 190, 407–425.
[202] Kim, S.A., Vacratsis, P.O., Firestein, R., Cleary, M.L. and Dixon, J.E. (2003)
Regulation of myotubularin-related (MTMR)2 phosphatidylinositol
phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl.
Acad. Sci. U.S.A. 100, 4492–4497.
[203] Cao, C., Backer, J.M., Laporte, J., Bedrick, E.J. and Wandinger-Ness, A. (2008)
Sequential actions of myotubularin lipid phosphatases regulate endosomal
PI(3)P and growth factor receptor trafﬁcking. Mol. Biol. Cell 19, 3334–3346.
[204] Chaussade, C. et al. (2003) Expression of myotubularin by an adenoviral
vector demonstrates its function as a phosphatidylinositol 3-phosphate
[PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in
insulin-stimulated glucose transport. Mol. Endocrinol. 17, 2448–2460.
[205] Srivastava, S. et al. (2006) Phosphatidylinositol-3 phosphatase
myotubularin-related protein 6 negatively regulates CD4 T cells. Mol. Cell.
Biol. 26, 5595–5602.
[206] Zou, J., Chang, S.C., Marjanovic, J. and Majerus, P.W. (2009) MTMR9 increases
MTMR6 enzyme activity, stability, and role in apoptosis. J. Biol. Chem. 284,
2064–2071.
[207] Zou, J., Zhang, C., Marjanovic, J., Kisseleva, M.V., Majerus, P.W. and Wilson,
M.P. (2012) Myotubularin-related protein (MTMR) 9 determines the
enzymatic activity, substrate speciﬁcity, and role in autophagy of MTMR8.
Proc. Natl. Acad. Sci. U.S.A. 109, 9539–9544.
[208] Robinson, F.L. and Dixon, J.E. (2006) Myotubularin phosphatases: policing 3-
phosphoinositides. Trends Cell Biol. 16, 403–412.
[209] Naughtin, M.J. et al. (2010) The myotubularin phosphatase MTMR4 regulates
sorting from early endosomes. J. Cell Sci. 123, 3071–3083.
[210] Yu, J., He, X., Chen, Y.G., Hao, Y., Yang, S., Wang, L., Pan, L. and Tang, H. (2012)
Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by
dephosphorylation of Smad proteins. J. Biol. Chem..
[211] Rehkop, D.M. and Etten, R.L. (1975) Human liver acid phosphatases. Hoppe
Seylers Z. Physiol. Chem. 356, 1775–1782.
[212] Wo, Y.Y., McCormack, A.L., Shabanowitz, J., Hunt, D.F., Davis, J.P., Mitchell,
G.L. and Van Etten, R.L. (1992) Sequencing, cloning, and expression of human
red cell-type acid phosphatase, a cytoplasmic phosphotyrosyl protein
phosphatase. J. Biol. Chem. 267, 10856–10865.
[213] Shekels, L.L., Smith, A.J., Van Etten, R.L. and Bernlohr, D.A. (1992)
Identiﬁcation of the adipocyte acid phosphatase as a PAO-sensitive tyrosyl
phosphatase. Protein Sci. 1, 710–721.
[214] Miller, D.T., Read, R., Rusconi, J. and Cagan, R.L. (2000) The Drosophila primo
locus encodes two low-molecular-weight tyrosine phosphatases. Gene 243,
1–9.
[215] Polzonetti, V., Passini, V. and Lucarini, N. (2011) Association between ACP(1)
genetic polymorphism and favism. Genet. Mol. Res. 10, 878–884.
[216] Teruel, M. et al. (2012) Novel association of acid phosphatase locus 1*C allele
with systemic lupus erythematosus. Hum. Immunol. 73, 107–110.
[217] Gloria-Bottini, F., Spina, C., Nicotra, M., Saccucci, P., Ambrosi, S. and Bottini, E.
(2012) Acid phosphatase locus 1 genetic polymorphism and cancer grading.
Am. J. Med. Sci. 344, 32–34.
[218] Edgar, B.A. and O’Farrell, P.H. (1989) Genetic control of cell division patterns
in the Drosophila embryo. Cell 57, 177–187.
[219] Inaba, M., Yuan, H. and Yamashita, Y.M. (2011) String (Cdc25) regulates stem
cell maintenance, proliferation and aging in Drosophila testis. Development
138, 5079–5086.
[220] Swaminathan, A. and Pile, L.A. (2010) Regulation of cell proliferation and
wing development by Drosophila SIN3 and String. Mech. Dev. 127, 96–106.
[221] Mukai, M., Kitadate, Y., Arita, K., Shigenobu, S. and Kobayashi, S. (2006)
Expression of meiotic genes in the germline progenitors of Drosophila
embryos. Gene Expr. Patterns 6, 256–266.
[222] Alphey, L., Jimenez, J., White-Cooper, H., Dawson, I., Nurse, P. and Glover,
D.M. (1992) Twine, a cdc25 homolog that functions in the male and female
germline of Drosophila. Cell 69, 977–988.
[223] Farrell, J.A. and O’Farrell, P.H. (2013) Mechanism and regulation of Cdc25/
Twine protein destruction in embryonic cell-cycle remodeling. Curr. Biol. 23,
118–126.
[224] Galaktionov, K. and Beach, D. (1991) Speciﬁc activation of cdc25 tyrosine
phosphatases by B-type cyclins: evidence for multiple roles of mitotic
cyclins. Cell 67, 1181–1194.
[225] Boldrini, L., Gisfredi, S., Ursino, S., Lucchi, M., Mussi, A. and Fontanini, G.
(2007) CDC25B: relationship with angiogenesis and prognosis in non-small
cell lung carcinoma. Hum. Pathol. 38, 1563–1568.
[226] Broggini, M. et al. (2000) Cell cycle-related phosphatases CDC25A and B
expression correlates with survival in ovarian cancer patients. Anticancer
Res. 20, 4835–4840.
[227] He, N. et al. (2005) Regulation of lung cancer cell growth and invasiveness by
beta-TRCP. Mol. Carcinog. 42, 18–28.
[228] Ito, Y., Yoshida, H., Uruno, T., Takamura, Y., Miya, A., Kuma, K. and Miyauchi,
A. (2004) Expression of cdc25A and cdc25B phosphatase in breast carcinoma.
Breast Cancer 11, 295–300.
966 T. Hatzihristidis et al. / FEBS Letters 589 (2015) 951–966[229] Russell, P., Moreno, S. and Reed, S.I. (1989) Conservation of mitotic controls
in ﬁssion and budding yeasts. Cell 57, 295–303.
[230] Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H. and
Okayama, H. (1994) Cdc25A is a novel phosphatase functioning early in the
cell cycle. EMBO J. 13, 1549–1556.
[231] Kiyokawa, H. and Ray, D. (2008) In vivo roles of CDC25 phosphatases:
biological insight into the anti-cancer therapeutic targets. Anticancer Agents
Med. Chem. 8, 832–836.
[232] Lindqvist, A., Kallstrom, H., Lundgren, A., Barsoum, E. and Rosenthal, C.K.
(2005) Cdc25B cooperates with Cdc25A to induce mitosis but has a unique
role in activating cyclin B1-Cdk1 at the centrosome. J. Cell Biol.
171, 35–45.
[233] Morillo, S.A., Braid, L.R., Verheyen, E.M. and Rebay, I. (2012) Nemo
phosphorylates eyes absent and enhances output from the Eya-Sine oculis
transcriptional complex during Drosophila retinal determination. Dev. Biol.
365, 267–276.
[234] Salzer, C.L., Elias, Y. and Kumar, J.P. (2010) The retinal determination gene
eyes absent is regulated by the EGF receptor pathway throughout
development in Drosophila. Genetics 184, 185–197.
[235] Pignoni, F., Hu, B., Zavitz, K.H., Xiao, J., Garrity, P.A. and Zipursky, S.L. (1997)
The eye-speciﬁcation proteins So and Eya form a complex and regulate
multiple steps in Drosophila eye development. Cell 91, 881–891.
[236] Fabrizio, J.J., Boyle, M. and DiNardo, S. (2003) A somatic role for eyes absent
(eya) and sine oculis (so) in Drosophila spermatocyte development. Dev. Biol.
258, 117–128.
[237] Bemmann, W. and Troger, R. (1975) The inﬂuence of hydrocarbon and
glucose medium on the fungi strains Absidia coerulea (p 23) and Penicillium
spec. (m 49). I. A comparison of growth in shake and standing culture
(author’s transl). Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 130, 505–
512.
[238] Bonini, N.M., Leiserson, W.M. and Benzer, S. (1993) The eyes absent gene:
genetic control of cell survival and differentiation in the developing
Drosophila eye. Cell 72, 379–395.
[239] Tadjuidje, E. and Hegde, R.S. (2012) The eyes absent proteins in development
and disease. Cell. Mol. Life Sci..
[240] Cook, P.J., Ju, B.G., Telese, F., Wang, X., Glass, C.K. and Rosenfeld, M.G. (2009)
Tyrosine dephosphorylation of H2AX modulates apoptosis and survival
decisions. Nature 458, 591–596.
[241] Amin, N.M., Lim, S.E., Shi, H., Chan, T.L. and Liu, J. (2009) A conserved Six-Eya
cassette acts downstream of Wnt signaling to direct non-myogenic versusmyogenic fates in the C. elegans postembryonic mesoderm. Dev. Biol. 331,
350–360.
[242] Bakhoum, M.F. and Jackson, G.R. (2011) Demise of the ﬂies: why Drosophila
models still matter. Prog. Mol. Biol. Transl. Sci. 100, 483–498.
[243] Paardekooper Overman, J. and den Hertog, J. (2013) Zebraﬁsh as a model to
study PTPs during development. Methods.
[244] Jaillon, O. et al. (2004) Genome duplication in the teleost ﬁsh Tetraodon
nigroviridis reveals the early vertebrate proto-karyotype. Nature 431, 946–
957.
[245] Vandepoele, K., De Vos, W., Taylor, J.S., Meyer, A. and Van de Peer, Y. (2004)
Major events in the genome evolution of vertebrates: paranome age and size
differ considerably between ray-ﬁnned ﬁshes and land vertebrates. Proc.
Natl. Acad. Sci. U.S.A. 101, 1638–1643.
[246] Sodergren, E. et al. (2006) The genome of the sea urchin Strongylocentrotus
purpuratus. Science 314, 941–952.
[247] Byrum, C.A., Walton, K.D., Robertson, A.J., Carbonneau, S., Thomason, R.T.,
Coffman, J.A. and McClay, D.R. (2006) Protein tyrosine and serine-threonine
phosphatases in the sea urchin, Strongylocentrotus purpuratus: identiﬁcation
and potential functions. Dev. Biol. 300, 194–218.
[248] Cohen, P. and Tcherpakov, M. (2010) Will the ubiquitin system furnish as
many drug targets as protein kinases? Cell 143, 686–693.
[249] Mohr, S.E., Smith, J.A., Shamu, C.E., Neumuller, R.A. and Perrimon, N. (2014)
RNAi screening comes of age: improved techniques and complementary
approaches. Nat. Rev. Mol. Cell Biol. 15, 591–600.
[250] Li, X., Wilmanns, M., Thornton, J. and Kohn, M. (2013) Elucidating human
phosphatase-substrate networks. Sci. Signal 6, rs10.
[251] Gaunt, M.W. and Miles, M.A. (2002) An insect molecular clock dates the
origin of the insects and accords with palaeontological and biogeographic
landmarks. Mol. Biol. Evol. 19, 748–761.
[252] Magis, C., Taly, J.F., Bussotti, G., Chang, J.M., Di Tommaso, P., Erb, I., Espinosa-
Carrasco, J. and Notredame, C. (2014) T-coffee: tree-based consistency
objective function for alignment evaluation. Methods Mol. Biol. 1079, 117–
129.
[253] Waterhouse, A.M., Procter, J.B., Martin, D.M., Clamp, M. and Barton, G.J.
(2009) Jalview version 2 – a multiple sequence alignment editor and analysis
workbench. Bioinformatics 25, 1189–1191.
[254] Felsenstein, J. (1989) PHYLIP – phylogeny inference package (version 3.2).
Cladistics 5, 164–166.
[255] Dray, S. and Dufour, A.B. (2007) The ade4 package: implementing the duality
diagram for ecologists. J. Stat. Softw. 22, 1–20.
